CN111607615B - 一种猪流行性腹泻、猪传染性胃肠炎病毒病二联亚单位疫苗的制备方法 - Google Patents

一种猪流行性腹泻、猪传染性胃肠炎病毒病二联亚单位疫苗的制备方法 Download PDF

Info

Publication number
CN111607615B
CN111607615B CN202010492987.9A CN202010492987A CN111607615B CN 111607615 B CN111607615 B CN 111607615B CN 202010492987 A CN202010492987 A CN 202010492987A CN 111607615 B CN111607615 B CN 111607615B
Authority
CN
China
Prior art keywords
val
leu
ser
thr
asn
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202010492987.9A
Other languages
English (en)
Other versions
CN111607615A (zh
Inventor
李雪峰
康斌
赵炳武
武玉梅
董鹏
王家福
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hangzhou Uben Animal Vaccine Co ltd
Jinhe Uben Biological Products Co ltd
Original Assignee
Hangzhou Uben Animal Vaccine Co ltd
Jinhe Uben Biological Products Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hangzhou Uben Animal Vaccine Co ltd, Jinhe Uben Biological Products Co ltd filed Critical Hangzhou Uben Animal Vaccine Co ltd
Priority to CN202010492987.9A priority Critical patent/CN111607615B/zh
Publication of CN111607615A publication Critical patent/CN111607615A/zh
Application granted granted Critical
Publication of CN111607615B publication Critical patent/CN111607615B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/14011Baculoviridae
    • C12N2710/14041Use of virus, viral particle or viral elements as a vector
    • C12N2710/14043Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vectore
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/20011Coronaviridae
    • C12N2770/20022New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Abstract

本发明提供了一种猪流行性腹泻、猪传染性胃肠炎病毒病二联亚单位疫苗的制备方法,属于动物疫苗与兽用生物制品技术领域,包括:将含PEDV‑T2A‑TGEV‑S序列的重组质粒转化感受态细胞、蓝白斑筛选,得到重组克隆;将重组克隆转染昆虫细胞,得到重组病毒,将所述重组病毒感染昆虫细胞,感染24h后,将蛋白酶抑制剂与培养基混合后继续培养,将得到的培养物离心,得到培养上清液,将所述培养上清液经30kDa超滤膜超滤、镍柱亲和层析,得到蛋白,将所述蛋白与佐剂混合,得到疫苗。采用本发明提供的方法经一次培养,就能够获得猪流行性腹泻、猪传染性胃肠炎病毒病二联亚单位疫苗。

Description

一种猪流行性腹泻、猪传染性胃肠炎病毒病二联亚单位疫苗 的制备方法
技术领域
本发明属于动物疫苗与兽用生物制品技术领域,尤其涉及一种猪流行性腹泻、猪传染性胃肠炎病毒病二联亚单位疫苗的制备方法。
背景技术
猪流行性腹泻(Porcine Epidemic Diarrhea,PED)是由猪流行性腹泻病毒(Porcine Epidemic Diarrhea Virus,PEDV)引起的一种以呕吐、腹泻和脱水为主要症状的肠道传染病。该病于1971年在英国首次暴发,1978年,比利时首次确认病原并报道,此后匈牙利、德国、日本、中国、韩国、越南等多个国家地区相继发生。猪流行腹泻多发于冬季及早春季节,夏季时有发生,对各种年龄阶段的猪均易感,尤其是7日龄以内的哺育仔猪感染率较高可达80-100%。近几年,该病在我国的发病率、死亡率均呈上升趋势,给养猪行业造成了重大经济损失。
猪传染性胃肠炎(Transmissible Gastroenteritis,TGE)是由猪传染性胃肠炎病毒引起猪的一种高度接触性消化道传染病。该病以呕吐、水样腹泻和脱水为特征,严重可导致死亡,不同品种和年龄的猪对该病都易感,尤其是2周龄以内的小猪死亡率可高达100%。
PEDV和TGEV均属冠状病毒科冠状病毒属成员,病毒粒子呈球形,直径约125nm,突出特征是颗粒表面有许多规则排列的刺突。病毒颗粒包含4个主要结构蛋白,分别是刺突蛋白(S),膜蛋白(M),囊膜蛋白(E)和核衣壳蛋白(N)。S蛋白属于I型膜糖蛋白,是最重要的抗原蛋白,可以识别宿主细胞表面受体分子,介导病毒进入细胞,诱导产生中和抗体。
目前市场上用于预防、控制猪流行性腹泻和传染性胃肠炎的疫苗基本都是传统PEDV弱毒苗和灭活疫苗。但是灭活疫苗存在自身免疫保护力较弱,且存在灭活不完全,造成散毒的风险;弱毒活疫苗存在毒株毒力返强的风险。随着分子生物学技术的飞速发展和研究的不断深入,研究者开始将疫苗的研发方向转为具有潜在优势的基因工程疫苗,该疫苗具有安全、高效、副作用小、表达量高、可工业化生产等优点。猪流行性腹泻和传染性胃肠炎亚单位疫苗的研究一直集中在S1蛋白的表达和疫苗研究(如中国专利申请号为201610348237.8的发明专利中使用昆虫杆状病毒表达S1区21-789位的蛋白),以及将S蛋白的核心区域的串联表达(如中国专利申请号为201610256701.0的发明专利中使用大肠杆菌串联表达S蛋白的3个核心区域),仅仅使用截短或者不完全的S蛋白作为抗原,存在抗原表位不全、免疫原性差等不足之处,导致免疫保护力度不够。近年来,也有将S蛋白完整表达(如中国专利申请号为CN201810310540.8的发明专利中使用CHO细胞表达PEDV的S全长蛋白),以及二联疫苗(如中国专利申请号为CN201710341489.2的发明专利中使用PEDV的S1和TGEV的S蛋白核心区域的串联表达)或三联疫苗(如中国专利申请号为CN201711093087.1的发明专利中通过三次培养分别生产三种病毒的S1蛋白),但一次培养即可生产这两种病毒亚单位疫苗的方法,还未见报道。
发明内容
有鉴于此,本发明的目的在于提供一种猪流行性腹泻、猪传染性胃肠炎病毒病二联亚单位疫苗的制备方法,经一次培养后就能够得到猪流行性腹泻、猪传染性胃肠炎病毒病二联亚单位疫苗。
为了实现上述发明目的,本发明提供了以下技术方案:
本发明提供了一种猪流行性腹泻、猪传染性胃肠炎病毒病二联亚单位疫苗的制备方法,包括以下步骤:
1)将PEDV-T2A-TGEV-S序列克隆到杆状病毒转移载体中,得到重组质粒;
所述PEDV-T2A-TGEV-S序列的核苷酸序列如SEQ ID No.1所示;
2)将所述步骤1)得到的重组质粒转化感受态细胞、蓝白斑筛选,得到重组克隆;
3)将所述步骤2)得到的重组克隆转染昆虫细胞,得到重组病毒,将所述重组病毒感染昆虫细胞,感染24h后,,将丝氨酸蛋白酶抑制剂、天冬氨酸蛋白酶抑制剂、氨基肽酶抑制剂、半胱氨酸蛋白酶抑制剂、丝氨酸/半胱氨酸蛋白酶抑制剂与培养基混合,得到含蛋白酶抑制剂培养物,将所述含蛋白酶抑制剂培养物继续培养48h,得到含表达蛋白的培养物;
所述含蛋白酶抑制剂培养物中丝氨酸蛋白酶抑制剂的浓度为2μg/ml;
所述含蛋白酶抑制剂培养物中天冬氨酸蛋白酶抑制剂的浓度为1μM;
所述含蛋白酶抑制剂培养物中氨基肽酶抑制剂的浓度为10μM;
所述含蛋白酶抑制剂培养物中半胱氨酸蛋白酶抑制剂的浓度为10μM;
所述含蛋白酶抑制剂培养物中丝氨酸/半胱氨酸蛋白酶抑制剂的浓度为100μM;
4)将所述步骤3)得到的培养物离心,得到培养上清液,将所述培养上清液经30kDa超滤膜超滤、镍柱亲和层析,得到纯化的蛋白,将所述纯化的蛋白与佐剂混合,得到猪流行性腹泻、猪传染性胃肠炎病毒病二联亚单位疫苗。
优选的,所述丝氨酸蛋白酶抑制剂包括Aprotinin;
所述天冬氨酸蛋白酶抑制剂包括Pepstatin A;
所述氨基肽酶抑制剂包括Bestatin;
所述半胱氨酸抑制剂包括E-64;
所述丝氨酸/半胱氨酸抑制剂包括Leupeptin。
优选的,所述步骤4)蛋白的氨基酸序列如SEQ ID No.2所示。
优选的,所述步骤1)杆状病毒转移载体包括pFastBacl载体。
优选的,所述步骤2)感受态细胞包括感受态细胞DH10Bac。
优选的,所述昆虫细胞包括Sf9、Sf21、Tn5、Tn368和HighFive细胞中的任一种。
优选的,所述步骤3)将传3代以后的重组病毒感染昆虫细胞。
优选的,所述步骤3)培养基以水为溶剂,每升包括45.9g Grace昆虫培养基、0.35g碳酸氢钠、3.3g水解乳蛋白和3.3g酵母提取物,所述培养基的pH值为6.2。
优选的,所述步骤3)培养的总时间为96h。
优选的,所述步骤4)蛋白与佐剂的质量比为1:1,所述佐剂包括ISA 201VG。
本发明提供了一种猪流行性腹泻、猪传染性胃肠炎病毒病二联亚单位疫苗的制备方法,本发明利用T2A多肽的自裂解特性,将PEDV和TGEV的S蛋白全长序列用T2A多肽串联起来,同时替换各自的信号肽为杆状病毒信号肽GP64,前体蛋白经裂解,信号肽引导到达内质网,经一系列翻译后加工修饰,形成2个成熟的S蛋白分泌表达到胞外。昆虫细胞拥有完备的翻译后加工修饰系统,使PEDV和TGEV的S蛋白形成具有良好抗原性的病毒样颗粒。PEDV和TGEV的S蛋白预测分子量分别为150kDa和157kDa,经糖基化修饰,实际分子量大于一般蛋白表达的分子量上限,蛋白分泌到培养基后的降解成为制约生产的瓶颈。本发明在培养基中添加水解乳蛋白和酵母提取物,通过增加外源蛋白,降低目的蛋白在培养物中的比例;同时在培养过程中添加多种蛋白酶抑制剂,抑制蛋白酶活性,两步并举防止蛋白酶降解目的蛋白。
附图说明
图1为pFastBac1载体图谱。
具体实施方式
本发明提供了一种猪流行性腹泻、猪传染性胃肠炎病毒病二联亚单位疫苗的制备方法,包括以下步骤:
1)将PEDV-T2A-TGEV-S序列克隆到杆状病毒转移载体中,得到重组质粒;
所述PEDV-T2A-TGEV-S序列的核苷酸序列如SEQ ID No.1所示;
2)将所述步骤1)得到的重组质粒转化感受态细胞、蓝白斑筛选,得到重组克隆;
3)将所述步骤2)得到的重组克隆转染昆虫细胞,得到重组病毒,将所述重组病毒感染昆虫细胞,感染24h后,将丝氨酸蛋白酶抑制剂、天冬氨酸蛋白酶抑制剂、氨基肽酶抑制剂、半胱氨酸蛋白酶抑制剂、丝氨酸/半胱氨酸蛋白酶抑制剂与培养基混合,得到含蛋白酶抑制剂培养物,将所述含蛋白酶抑制剂培养物继续培养,得到含目的蛋白培养物;
所述含抑制剂培养物中丝氨酸蛋白酶抑制剂的浓度为2μg/ml;
所述含抑制剂培养物中天冬氨酸蛋白酶抑制剂的浓度为1μM;
所述含抑制剂培养物中氨基肽酶抑制剂的浓度为10μM;
所述含抑制剂培养物中半胱氨酸蛋白酶抑制剂的浓度为10μM;
所述含抑制剂培养物中丝氨酸/半胱氨酸蛋白酶抑制剂的浓度为100μM;
4)将所述步骤3)得到的培养物离心,得到培养上清液,将所述培养上清液经30kDa超滤膜超滤、镍柱亲和层析,得到纯化的蛋白,将所述纯化的蛋白与佐剂混合,得到猪流行性腹泻、猪传染性胃肠炎病毒病二联亚单位疫苗。
在本发明中,所述PEDV-T2A-TGEV-S序列的核苷酸序列如SEQ ID No.1所示,具体如下:
ctcgagatggtgtccgctattgtgttatacgtcctgttagctgctgccgcgcacagtgcctttgcgttgcctcaagacgttacacgatgctctgcaaacacaaacttccgacgattcttctcaaaattcaacgtgcaggcaccagcagttgtagttctaggaggatacctgccaatcggagagaatcaaggagttaactctacatggtactgcgcaggacagcatccaacagcatccggcgttcatggtatattcgtttctcatatccgaggaggacatggattcgaaatcggaatctctcaggaaccattcgatccatctggataccagctttaccttcataaagcaacaaacggaaacacaaacgcaacagcacgacttcgaatctgccagttcccatctatcaagaccttaggaccaacagcaaacaacgatgttacaacaggacgaaactgcttattcaacaaggccataccagcacatatgtctgaacattctgttgttggaatcacatgggataacgatcgagttacggtattcagcgataagatatactacttctacttcaagaatgactggtctcgggtagctactaaatgctataactctggaggatgcgcaatgcagtacgtttacgaaccaacatactacatgcttaatgtcacctccgccggcgaagatggaatctcttaccagccatgcacagcaaactgcatcggatactctgctaatgtctttgcgaccgaaccaaacggacatatcccagaaggattcagcttcaacaactggttcttgcttagtaatgattccacgttggtgcacgggaaggtggtgtcgaatcagccactactagtgaattgtttattggcgatcccaaagatatatggacttggacagttcttcagcttcaatcaaactatagacggcgtgtgtaatggtgctgccgtgcagcgagcaccagaagcacttcgattcaacatcaacgatacatctgttatccttgcagaaggatctatcgttcttcatacagcacttggaacaaacttcagcttcgtttgctctaactcttctgatccacatcttgcaacattcgcaatcccacttggagcaatccaggttccatactactgcttccttaaagttgatacatacaactctacagtttacaaattcctgtcagtgttgcctcctacggtgagagagattgtcatcacaaagtatggcgatgtttacgttaacggattcggataccttcatcttggacttcttgatgcagttacaatcaacttcacaggacatggaacagatgatgatgtttctggattctggacgattgcaagcaccaactttgtcgatgcgctaatcgaagttcagggcacggctattcaaaggatcctttactgcgatgatccagtttctcagcttaaatgctcacaggtcgctttcgatcttgatgatggcttctaccctatcagctctcgaaaccttctttctcatgaacaacccattagtttcgtggccctgccgtcatttaatgaccattctttcgtgaacattacggtatcagcatctttcggaggacattctggagcaaaccttatcgcatctgatacaacaatcaacggattcagtagtttctgcgtggatacacgacagtttactatcagcttattctataatgtaacaaactcgtatggctacgtttctaaatctcaggattctaactgcccattcacacttcagtctgttaacgattacctttctttcagtaaattctgcgtgtctacctcactcttggccagtgcttgtaccatcgatctctttggttacccagaattcggatctggagttaaattcacatctctttacttccagttcacaaagggtgagttgattaccggtactagcaaaccacttgaaggtgttacggacgtcagcttcatgaccttagacgtctgtacaaagtatactatttatggattcaaaggagaaggaatcatcacattaacaaacagctcgttcttagcaggagtatattatacttcagacagtggacaactgttggcgttcaagaatgtaacgagtggcgctgtatatagcgtaacgccgtgcagcttctccgagcaggcagcatacgttgatgatgatatagtgggtgtcatttcatctctttcttcttctacattcaactctacacgagaacttccaggattcttctaccacagcaatgacggtagcaattgtactgagccggttcttgtttatagtaatataggcgtatgcaagagcggttctatcggatacgttccatctcagtctggacaggttaagatagcgcccaccgttacaggaaacatctctataccgacaaactttagcatgagtatccgaacagaataccttcagctttacaacactcctgtgtccgtagactgcgcaacatacgtgtgcaacggtaacagtagatgcaaacagctgttaacccaatatactgcggcatgcaagaccattgaatctgctctccaactctccgcgcggctggagtcggtcgaagttaactctatgcttacaatctctgaagaagctttacaattagcgaccataagtagctttaatggagatggttataatttcaccaacgttcttggagtttctgtttacgatccagcatctggacgagttgttcagaaacgatctttcattgaggacctgctctttaataaggtcgttacgaatggtctcggtactgtagacgaggactataagagatgtagtaacggacgatctgttgcggacttggtatgtgctcaatattattccggtgttatggtcttgcccggtgtagtcgatgcagagaagttgcacatgtattctgcatctcttatcggaggaatggtgttgggtgggtttacctctgcagcagcacttccattctcttacgccgtacaagctcgtttgaattatcttgcgctacaaactgatgttctccagcggaaccagcaactgctcgcggagtcgtttaatagtgccattgggtctatcacatctgcattcgaatccgtcaaggaggctatatctcagacatctaaaggacttaacacagttgcacatgcacttactaaggtccaagaagttgttaactctcagggagcagcacttacacagctgacggtgcaattacaacacaatttccaggcgataagcagtagtatagacgacatctactctcgacttgatatcctctcagctgacgtgcaggtagaccgcctaataactggacgacttagcgcactgaatgctttcgtagcacagacgttaaccaagtatacagaagttcgtgcttcccgtaaacttgctcagcagaaggtcaacgaatgcgtaaagagtcagtcgcaacgctatggattctgcggtggagacggcgaacatatcttctctcttgttcaggcagcaccacagggactcttatttctgcacactgtcctagtaccgggagactttgtcgatgtaatcgctatagcaggactttgcgttaacgatgaaatcgcacttacacttcgagaaccaggacttgttctgtttactcatgaacttcagaaccatacagcaacagaatacttcgtttcttctcgacgaatgttcgaaccacgaaagccgaccgtcagtgactttgtgcaaattgagtcctgtgttgttacatacgttaaccttacacgagatcagcttccagatgttataccggattacatcgatgtaaacaagaccttagatgaaattctcgcttcgctcccgaaccgaacaggaccatctcttcctctagacgtgttcaacgcaacgtatttaaatctcacgggtgagatcgcagatcttgaacaacgatctgaatctcttcgaaacacaacagaagaacttcagtctcttatctacaatataaataatacattagtggatctggaatggctcaatcgggtcgagacatacatcaagtggccgtggtgggtgtggcttatcatcttcatcgttcttatcttcgttgtatccctgctagtattctgttgtatatctaccggatgctgcggttgctgcggttgctgctgtgcgtgcttctctggatgctgccgaggaccacgacttcagccatacgaagtctttgagaaagttcatgtccaacatcaccaccaccaccacggctcaggagaaggacgaggatctcttcttacatgcggagatgttgaagagaatcccggaccagtctccgccatagtattgtacgtacttctcgccgccgctgcccactcagcctttgccgacaatttcccatgctctaaacttactaataggacgataggcaaccagtggaaccttatcgaaacattccttcttaactactcttctcgacttccaccaaactctgatgtggtgttgggcgactatttcccaacagttcagccatggttcaactgcatccgaaacgacagcaatgacttgtatgtgaccctggagaatctaaaggcgttatactgggattacgcaacagagaatattacatggaaccatcgacagcgacttaacgttgttgttaacggatacccatactctatcacagttacaacaacacgaaactttaatagtgctgagggtgcaatcatctgcatctgcaaaggatctccaccaacaacaacaacagaatcttctcttacatgcaactggggctctgagtgccgacttaaccataaattcccaatctgcccatctaactctgaagcaaactgcggaaacatgctttacggacttcagtggttcgcagatgaagttgttgcataccttcatggagcatcttaccgaatctctttcgagaatcaatggtctggaacagttacattcggagatatgcgagcaacaacacttgaagttgcaggaacgctcgtcgacctatggtggttcaacccagtttacgatgtttcttactaccgagttaacaacaagaatgggacaacagtagtcagtaattgtaccgatcagtgtgcatcttacgttgccaatgtgtttacaacgcagccaggaggattcatcccatctgatttttcttttaataattggtttttgcttacaaatagctccacactggtgtcgggcaaattggtcacaaagcagcctctactcgtcaattgtctctggcctgttccatctttcgaagaagcagcatctacattctgcttcgaaggagcaggattcgatcagtgcaacggagcggtgttaaacaacacagtggacgtaatacgctttaaccttaacttcacaacaaacgttcagtctggaaagggcgctacggtattctcactcaatacaacaggaggagtcacgctagagatttcatgctacacagtatcggatagttcattcttctcctacggagagattccattcggcgtaaccgacggccctcgatactgctacgttcattacaacggaacagcacttaaataccttggaacacttccaccatccgtaaaggagattgctatctctaaatggggccacttctatattaacggctataatttcttctcaacctttcccatcgattgcatatcatttaatctgacgacaggagattctgatgtattctggaccatagcgtatacgtcttacacagaagcattggtgcaagttgagaataccgcaatcacaaaggtgacctactgcaactctcatgttaacaacatcaaatgctcccagataacagcaaaccttaacaacgggttctaccctgtaagctcttctgaagtcgggctagtaaataagtctgttgtgttgctacccagcttctatactcatacaattgtgaatattaccattggccttggaatgaaacgatctggatacggacagcctatagcttcgactttaagtaacatcacacttccaatgcaggatcataacacagatgtttactgcatccgatctgatcagttctctgtttacgttcattctacatgcaaatctgcactttgggataacatcttcaaacgaaattgtacagatgttctagacgcgacagcagttatcaagactgggacatgcccattctctttcgataaacttaacaactaccttacattcaacaaattctgcctttctctttctccagttggagcaaactgcaaattcgatgttgcagcacgaacacgaacaaacgaacaggttgttcgatctctttacgttatctacgaagaaggagataacattgtcggtgtgccgtcagataactcaggcgttcatgacttgagtgtgctacacttagattcttgcacagattacaacatctacggacgaacaggagttggaatcatccgacagacgaatcggactctactgtctggattatattatacgtcattaagcggagatcttcttggatttaagaatgtgtcggacggagttatctattcggtgactccgtgcgacgtatctgcacaggcagcagttatcgatggaacaatcgttggagcaatcacatctatcaactctgaacttcttggacttacacattggacaacaacaccaaacttctactactactctatctacaactacacaaacgatcgaacacgagggacggctatagacagtaacgatgtcgattgcgaaccagttatcacatattcgaatataggcgtgtgtaagaatggcgctttcgtcttcataaacgttacacatagtgacggcgacgtccagcccatttctactgggaatgtaacaattcctaccaatttcactatttcggtgcaagtcgaatacatccaggtttacacaacgccggtatccattgactgctctcgatacgtatgcaacggaaaccctcggtgcaataagctgttgacacaatatgtgtccgcatgccaaaccatagagcaagcacttgcaatgggagctcgactggagaatatggaggttgattctatgctgtttgtatctgagaatgcgcttaaacttgcatctgttgaagcattcaactcttctgaaacacttgatccaatctacaaagaatggccaaacatcggaggatcttggcttgaatctcttaaatacatccttccatctcataactctaaacgaaagtatagatctgcaatagaggacttactatttgacaaagtggttacatctgggttgggcaccgtggacgaggactataagcgctgtacaggtgggtatgatatagccgatcttgtgtgcgcgcaatattataatggtatcatggtcctcccgggaggggctaatgcagataagatgacgatgtacacagcatctcttgcatctggaatcacacttggagcacttggaggaggagcagttgcaatcccattcgcagttgctgtgcaagcgagactcaattatgtggcgttacaaaccgatgttctaaacaagaatcaacagatattagcatctgcattcaatcaggcaatcggaaacatcacacagtctttcggaaaggtgaatgatgcaatccatcagacatcccgaggacttgcaacagttgcaaaggctttagcgaaagttcaggacgtagttaacatccagggacaggcactctcacacctgacagttcaactgcagaacaacttccaggcgattagctcatctatatcagacatctacaaccgacttgatgaattatccgctgacgctcaggtggacagactaatcacgggacggctaaccgcgctcaatgcgtttgtaagtcagactctcacgcgccaagccgaggtgagggcgagtcggcaattggcaaaggacaaagtgaacgaatgcgttcgatctcaatcccaacgtttcgggttctgtggaaatgggacacacttgttctctttagccaacgcagcaccaaacggaatgatcttcttccacaccgtcctactgcccaccgcgtacgaaacagttacagcatggccaggaatctgcgcatcggacggcgacagaacctttggtctagtcgtgaaggacgttcagcttacattatttcgtaaccttgatgataaattctaccttacaccacgaacaatgtaccagccacgcgtagcgactagttcagatttcgttcagatagagggctgtgatgttctgtttgtcaacgccacggtttcagatttgccatctatcatccctgactatatagatattaaccagacagttcaggatatccttgagaatttccgtcccaactggacagttccagaacttacattcgatatctttaatgccacctatctgaatttaaccggtgaaatagacgaccttgaattccgatctgagaagcttcacaatacgacagttgaacttgcaatccttatcgataatattaataataccttagtgaatttagagtggctgaatcggatagagacatacgttaagtggccctggtatgtctggcttcttattgggttggtcgtaatattctgtataccacttcttctcttctgctgttgcagcactggttgctgcgggtgcatcggatgccttggatcttgctgccattctatctgctctcgacgacaatttgagaattatgaaccagttgagaaggttcacgtgcaccaccatcatcatcattgaggtacc。
在本发明中,所述PEDV-T2A-TGEV-S序列依次为:一段GP64信号肽序列,大小为60个碱基,其核苷酸序列如SEQ ID NO.3所示;PEDV的S蛋白序列,大小为4104个碱基,其碱基序列如SEQ ID NO.4所示;6组氨酸His标签,大小为18个碱基,其碱基序列如SEQ ID NO.5所示;一段自剪切序列T2A,大小为63个碱基,其核苷酸序列如SEQ ID NO.6所示;一段GP64信号肽序列,大小为57个碱基,其核苷酸序列如SEQ ID NO.7所示;TGEV的S蛋白序列,大小为4290个碱基,其碱基序列如SEQ ID NO.8所示;6组氨酸His标签,大小为18个碱基,其碱基序列如SEQ ID NO.9所示;序列的两端分别含有XhoI和KpnI酶切位点。
SEQ ID NO.3:
atggtgtccgctattgtgttatacgtcctgttagctgctgccgcgcacagtgcctttgcg。
SEQ ID NO.4:
ttgcctcaagacgttacacgatgctctgcaaacacaaacttccgacgattcttctcaaaattcaacgtgcaggcaccagcagttgtagttctaggaggatacctgccaatcggagagaatcaaggagttaactctacatggtactgcgcaggacagcatccaacagcatccggcgttcatggtatattcgtttctcatatccgaggaggacatggattcgaaatcggaatctctcaggaaccattcgatccatctggataccagctttaccttcataaagcaacaaacggaaacacaaacgcaacagcacgacttcgaatctgccagttcccatctatcaagaccttaggaccaacagcaaacaacgatgttacaacaggacgaaactgcttattcaacaaggccataccagcacatatgtctgaacattctgttgttggaatcacatgggataacgatcgagttacggtattcagcgataagatatactacttctacttcaagaatgactggtctcgggtagctactaaatgctataactctggaggatgcgcaatgcagtacgtttacgaaccaacatactacatgcttaatgtcacctccgccggcgaagatggaatctcttaccagccatgcacagcaaactgcatcggatactctgctaatgtctttgcgaccgaaccaaacggacatatcccagaaggattcagcttcaacaactggttcttgcttagtaatgattccacgttggtgcacgggaaggtggtgtcgaatcagccactactagtgaattgtttattggcgatcccaaagatatatggacttggacagttcttcagcttcaatcaaactatagacggcgtgtgtaatggtgctgccgtgcagcgagcaccagaagcacttcgattcaacatcaacgatacatctgttatccttgcagaaggatctatcgttcttcatacagcacttggaacaaacttcagcttcgtttgctctaactcttctgatccacatcttgcaacattcgcaatcccacttggagcaatccaggttccatactactgcttccttaaagttgatacatacaactctacagtttacaaattcctgtcagtgttgcctcctacggtgagagagattgtcatcacaaagtatggcgatgtttacgttaacggattcggataccttcatcttggacttcttgatgcagttacaatcaacttcacaggacatggaacagatgatgatgtttctggattctggacgattgcaagcaccaactttgtcgatgcgctaatcgaagttcagggcacggctattcaaaggatcctttactgcgatgatccagtttctcagcttaaatgctcacaggtcgctttcgatcttgatgatggcttctaccctatcagctctcgaaaccttctttctcatgaacaacccattagtttcgtggccctgccgtcatttaatgaccattctttcgtgaacattacggtatcagcatctttcggaggacattctggagcaaaccttatcgcatctgatacaacaatcaacggattcagtagtttctgcgtggatacacgacagtttactatcagcttattctataatgtaacaaactcgtatggctacgtttctaaatctcaggattctaactgcccattcacacttcagtctgttaacgattacctttctttcagtaaattctgcgtgtctacctcactcttggccagtgcttgtaccatcgatctctttggttacccagaattcggatctggagttaaattcacatctctttacttccagttcacaaagggtgagttgattaccggtactagcaaaccacttgaaggtgttacggacgtcagcttcatgaccttagacgtctgtacaaagtatactatttatggattcaaaggagaaggaatcatcacattaacaaacagctcgttcttagcaggagtatattatacttcagacagtggacaactgttggcgttcaagaatgtaacgagtggcgctgtatatagcgtaacgccgtgcagcttctccgagcaggcagcatacgttgatgatgatatagtgggtgtcatttcatctctttcttcttctacattcaactctacacgagaacttccaggattcttctaccacagcaatgacggtagcaattgtactgagccggttcttgtttatagtaatataggcgtatgcaagagcggttctatcggatacgttccatctcagtctggacaggttaagatagcgcccaccgttacaggaaacatctctataccgacaaactttagcatgagtatccgaacagaataccttcagctttacaacactcctgtgtccgtagactgcgcaacatacgtgtgcaacggtaacagtagatgcaaacagctgttaacccaatatactgcggcatgcaagaccattgaatctgctctccaactctccgcgcggctggagtcggtcgaagttaactctatgcttacaatctctgaagaagctttacaattagcgaccataagtagctttaatggagatggttataatttcaccaacgttcttggagtttctgtttacgatccagcatctggacgagttgttcagaaacgatctttcattgaggacctgctctttaataaggtcgttacgaatggtctcggtactgtagacgaggactataagagatgtagtaacggacgatctgttgcggacttggtatgtgctcaatattattccggtgttatggtcttgcccggtgtagtcgatgcagagaagttgcacatgtattctgcatctcttatcggaggaatggtgttgggtgggtttacctctgcagcagcacttccattctcttacgccgtacaagctcgtttgaattatcttgcgctacaaactgatgttctccagcggaaccagcaactgctcgcggagtcgtttaatagtgccattgggtctatcacatctgcattcgaatccgtcaaggaggctatatctcagacatctaaaggacttaacacagttgcacatgcacttactaaggtccaagaagttgttaactctcagggagcagcacttacacagctgacggtgcaattacaacacaatttccaggcgataagcagtagtatagacgacatctactctcgacttgatatcctctcagctgacgtgcaggtagaccgcctaataactggacgacttagcgcactgaatgctttcgtagcacagacgttaaccaagtatacagaagttcgtgcttcccgtaaacttgctcagcagaaggtcaacgaatgcgtaaagagtcagtcgcaacgctatggattctgcggtggagacggcgaacatatcttctctcttgttcaggcagcaccacagggactcttatttctgcacactgtcctagtaccgggagactttgtcgatgtaatcgctatagcaggactttgcgttaacgatgaaatcgcacttacacttcgagaaccaggacttgttctgtttactcatgaacttcagaaccatacagcaacagaatacttcgtttcttctcgacgaatgttcgaaccacgaaagccgaccgtcagtgactttgtgcaaattgagtcctgtgttgttacatacgttaaccttacacgagatcagcttccagatgttataccggattacatcgatgtaaacaagaccttagatgaaattctcgcttcgctcccgaaccgaacaggaccatctcttcctctagacgtgttcaacgcaacgtatttaaatctcacgggtgagatcgcagatcttgaacaacgatctgaatctcttcgaaacacaacagaagaacttcagtctcttatctacaatataaataatacattagtggatctggaatggctcaatcgggtcgagacatacatcaagtggccgtggtgggtgtggcttatcatcttcatcgttcttatcttcgttgtatccctgctagtattctgttgtatatctaccggatgctgcggttgctgcggttgctgctgtgcgtgcttctctggatgctgccgaggaccacgacttcagccatacgaagtctttgagaaagttcatgtccaa。
SEQ ID No.5:catcaccaccaccaccac。
SEQ ID No.6:
ggctcaggagaaggacgaggatctcttcttacatgcggagatgttgaagagaatcccggacca。
SEQ ID No.7:
gtctccgccatagtattgtacgtacttctcgccgccgctgcccactcagcctttgcc。
SEQ ID No.8:
gacaatttcccatgctctaaacttactaataggacgataggcaaccagtggaaccttatcgaaacattccttcttaactactcttctcgacttccaccaaactctgatgtggtgttgggcgactatttcccaacagttcagccatggttcaactgcatccgaaacgacagcaatgacttgtatgtgaccctggagaatctaaaggcgttatactgggattacgcaacagagaatattacatggaaccatcgacagcgacttaacgttgttgttaacggatacccatactctatcacagttacaacaacacgaaactttaatagtgctgagggtgcaatcatctgcatctgcaaaggatctccaccaacaacaacaacagaatcttctcttacatgcaactggggctctgagtgccgacttaaccataaattcccaatctgcccatctaactctgaagcaaactgcggaaacatgctttacggacttcagtggttcgcagatgaagttgttgcataccttcatggagcatcttaccgaatctctttcgagaatcaatggtctggaacagttacattcggagatatgcgagcaacaacacttgaagttgcaggaacgctcgtcgacctatggtggttcaacccagtttacgatgtttcttactaccgagttaacaacaagaatgggacaacagtagtcagtaattgtaccgatcagtgtgcatcttacgttgccaatgtgtttacaacgcagccaggaggattcatcccatctgatttttcttttaataattggtttttgcttacaaatagctccacactggtgtcgggcaaattggtcacaaagcagcctctactcgtcaattgtctctggcctgttccatctttcgaagaagcagcatctacattctgcttcgaaggagcaggattcgatcagtgcaacggagcggtgttaaacaacacagtggacgtaatacgctttaaccttaacttcacaacaaacgttcagtctggaaagggcgctacggtattctcactcaatacaacaggaggagtcacgctagagatttcatgctacacagtatcggatagttcattcttctcctacggagagattccattcggcgtaaccgacggccctcgatactgctacgttcattacaacggaacagcacttaaataccttggaacacttccaccatccgtaaaggagattgctatctctaaatggggccacttctatattaacggctataatttcttctcaacctttcccatcgattgcatatcatttaatctgacgacaggagattctgatgtattctggaccatagcgtatacgtcttacacagaagcattggtgcaagttgagaataccgcaatcacaaaggtgacctactgcaactctcatgttaacaacatcaaatgctcccagataacagcaaaccttaacaacgggttctaccctgtaagctcttctgaagtcgggctagtaaataagtctgttgtgttgctacccagcttctatactcatacaattgtgaatattaccattggccttggaatgaaacgatctggatacggacagcctatagcttcgactttaagtaacatcacacttccaatgcaggatcataacacagatgtttactgcatccgatctgatcagttctctgtttacgttcattctacatgcaaatctgcactttgggataacatcttcaaacgaaattgtacagatgttctagacgcgacagcagttatcaagactgggacatgcccattctctttcgataaacttaacaactaccttacattcaacaaattctgcctttctctttctccagttggagcaaactgcaaattcgatgttgcagcacgaacacgaacaaacgaacaggttgttcgatctctttacgttatctacgaagaaggagataacattgtcggtgtgccgtcagataactcaggcgttcatgacttgagtgtgctacacttagattcttgcacagattacaacatctacggacgaacaggagttggaatcatccgacagacgaatcggactctactgtctggattatattatacgtcattaagcggagatcttcttggatttaagaatgtgtcggacggagttatctattcggtgactccgtgcgacgtatctgcacaggcagcagttatcgatggaacaatcgttggagcaatcacatctatcaactctgaacttcttggacttacacattggacaacaacaccaaacttctactactactctatctacaactacacaaacgatcgaacacgagggacggctatagacagtaacgatgtcgattgcgaaccagttatcacatattcgaatataggcgtgtgtaagaatggcgctttcgtcttcataaacgttacacatagtgacggcgacgtccagcccatttctactgggaatgtaacaattcctaccaatttcactatttcggtgcaagtcgaatacatccaggtttacacaacgccggtatccattgactgctctcgatacgtatgcaacggaaaccctcggtgcaataagctgttgacacaatatgtgtccgcatgccaaaccatagagcaagcacttgcaatgggagctcgactggagaatatggaggttgattctatgctgtttgtatctgagaatgcgcttaaacttgcatctgttgaagcattcaactcttctgaaacacttgatccaatctacaaagaatggccaaacatcggaggatcttggcttgaatctcttaaatacatccttccatctcataactctaaacgaaagtatagatctgcaatagaggacttactatttgacaaagtggttacatctgggttgggcaccgtggacgaggactataagcgctgtacaggtgggtatgatatagccgatcttgtgtgcgcgcaatattataatggtatcatggtcctcccgggaggggctaatgcagataagatgacgatgtacacagcatctcttgcatctggaatcacacttggagcacttggaggaggagcagttgcaatcccattcgcagttgctgtgcaagcgagactcaattatgtggcgttacaaaccgatgttctaaacaagaatcaacagatattagcatctgcattcaatcaggcaatcggaaacatcacacagtctttcggaaaggtgaatgatgcaatccatcagacatcccgaggacttgcaacagttgcaaaggctttagcgaaagttcaggacgtagttaacatccagggacaggcactctcacacctgacagttcaactgcagaacaacttccaggcgattagctcatctatatcagacatctacaaccgacttgatgaattatccgctgacgctcaggtggacagactaatcacgggacggctaaccgcgctcaatgcgtttgtaagtcagactctcacgcgccaagccgaggtgagggcgagtcggcaattggcaaaggacaaagtgaacgaatgcgttcgatctcaatcccaacgtttcgggttctgtggaaatgggacacacttgttctctttagccaacgcagcaccaaacggaatgatcttcttccacaccgtcctactgcccaccgcgtacgaaacagttacagcatggccaggaatctgcgcatcggacggcgacagaacctttggtctagtcgtgaaggacgttcagcttacattatttcgtaaccttgatgataaattctaccttacaccacgaacaatgtaccagccacgcgtagcgactagttcagatttcgttcagatagagggctgtgatgttctgtttgtcaacgccacggtttcagatttgccatctatcatccctgactatatagatattaaccagacagttcaggatatccttgagaatttccgtcccaactggacagttccagaacttacattcgatatctttaatgccacctatctgaatttaaccggtgaaatagacgaccttgaattccgatctgagaagcttcacaatacgacagttgaacttgcaatccttatcgataatattaataataccttagtgaatttagagtggctgaatcggatagagacatacgttaagtggccctggtatgtctggcttcttattgggttggtcgtaatattctgtataccacttcttctcttctgctgttgcagcactggttgctgcgggtgcatcggatgccttggatcttgctgccattctatctgctctcgacgacaatttgagaattatgaaccagttgagaaggttcacgtg。
SEQ ID No.9:caccaccatcatcatcat。
在本发明中,所述杆状病毒转移载体优选包括pFastBacl载体,本发明对将PEDV-T2A-TGEV-S序列克隆到杆状病毒转移载体中的克隆方法没有特殊限定,采用常规克隆方法即可。
本发明将得到的重组质粒转化感受态细胞、蓝白斑筛选,得到重组克隆。在本发明中,所述感受态细胞优选包括感受态细胞DH10Bac。本发明对所述转化、蓝白斑筛选的方法没有特殊限定,采用本领域熟知的方法即可。
本发明将得到的重组克隆转染昆虫细胞,得到重组病毒,将所述重组病毒感染昆虫细胞,感染24h后,将丝氨酸蛋白酶抑制剂、天冬氨酸蛋白酶抑制剂、氨基肽酶抑制剂、半胱氨酸蛋白酶抑制剂、丝氨酸/半胱氨酸蛋白酶抑制剂与培养基混合,得到含蛋白酶抑制剂培养物,将所述含蛋白酶抑制剂培养物继续培养,得到含表达蛋白培养物。
在本发明中,所述丝氨酸蛋白酶抑制剂能够抑制丝氨酸蛋白酶活性;所述天冬氨酸蛋白酶抑制剂能够抑制天冬氨酸蛋白酶活性;所述氨基肽酶抑制剂能够抑制氨基肽酶活性;所述丝氨酸/半胱氨酸蛋白酶抑制剂能够抑制丝氨酸和半胱氨酸蛋白酶活性。在本发明中,所述昆虫细胞优选包括Sf9、Sf21、Tn5、Tn368和HighFive细胞中的任一种。本发明优选将传3代以后的重组病毒感染昆虫细胞,所述重组病毒的接种量优选为0.1个MOI。在本发明中,所述培养基优选以水为溶剂,每升包括45.9gGrace昆虫培养基、0.35g碳酸氢钠、3.3g水解乳蛋白和3.g酵母提取物,所述培养基的pH值为6.2。在本发明中,所述培养的总时间为96h。
在本发明中,所述含蛋白酶抑制剂培养物中丝氨酸蛋白酶抑制剂的浓度为2μg/ml;所述含蛋白酶抑制剂培养物中天冬氨酸蛋白酶抑制剂的浓度为1μM;所述含蛋白酶抑制剂培养物中氨基肽酶抑制剂的浓度为10μM;所述含蛋白酶抑制剂培养物中半胱氨酸蛋白酶抑制剂的浓度为10μM;所述含蛋白酶抑制剂培养物中丝氨酸/半胱氨酸蛋白酶抑制剂的浓度为100μM。在本发明中,所述丝氨酸蛋白酶抑制剂优选包括Aprotinin;所述天冬氨酸蛋白酶抑制剂优选包括Pepstatin A;所述氨基肽酶抑制剂优选包括Bestatin;所述半胱氨酸蛋白酶抑制剂优选包括E-64;所述丝氨酸/半胱氨酸蛋白酶抑制剂优选包括Leupeptin。在本发明中,在制备疫苗的过程中添加多种蛋白酶抑制剂,从而抑制蛋白酶活性,防止蛋白降解。
在本发明中,所述蛋白为PEDV-T2A-TGEV-S序列编码的蛋白,所述蛋白的氨基酸序列如SEQ ID No.2所示,具体如下:
MVSAIVLYVLLAAAAHSAFALPQDVTRCSANTNFRRFFSKFNVQAPAVVVLGGYLPIGENQGVNSTWYCAGQHPTASGVHGIFVSHIRGGHGFEIGISQEPFDPSGYQLYLHKATNGNTNATARLRICQFPSIKTLGPTANNDVTTGRNCLFNKAIPAHMSEHSVVGITWDNDRVTVFSDKIYYFYFKNDWSRVATKCYNSGGCAMQYVYEPTYYMLNVTSAGEDGISYQPCTANCIGYSANVFATEPNGHIPEGFSFNNWFLLSNDSTLVHGKVVSNQPLLVNCLLAIPKIYGLGQFFSFNQTIDGVCNGAAVQRAPEALRFNINDTSVILAEGSIVLHTALGTNFSFVCSNSSDPHLATFAIPLGAIQVPYYCFLKVDTYNSTVYKFLSVLPPTVREIVITKYGDVYVNGFGYLHLGLLDAVTINFTGHGTDDDVSGFWTIASTNFVDALIEVQGTAIQRILYCDDPVSQLKCSQVAFDLDDGFYPISSRNLLSHEQPISFVALPSFNDHSFVNITVSASFGGHSGANLIASDTTINGFSSFCVDTRQFTISLFYNVTNSYGYVSKSQDSNCPFTLQSVNDYLSFSKFCVSTSLLASACTIDLFGYPEFGSGVKFTSLYFQFTKGELITGTSKPLEGVTDVSFMTLDVCTKYTIYGFKGEGIITLTNSSFLAGVYYTSDSGQLLAFKNVTSGAVYSVTPCSFSEQAAYVDDDIVGVISSLSSSTFNSTRELPGFFYHSNDGSNCTEPVLVYSNIGVCKSGSIGYVPSQSGQVKIAPTVTGNISIPTNFSMSIRTEYLQLYNTPVSVDCATYVCNGNSRCKQLLTQYTAACKTIESALQLSARLESVEVNSMLTISEEALQLATISSFNGDGYNFTNVLGVSVYDPASGRVVQKRSFIEDLLFNKVVTNGLGTVDEDYKRCSNGRSVADLVCAQYYSGVMVLPGVVDAEKLHMYSASLIGGMVLGGFTSAAALPFSYAVQARLNYLALQTDVLQRNQQLLAESFNSAIGSITSAFESVKEAISQTSKGLNTVAHALTKVQEVVNSQGAALTQLTVQLQHNFQAISSSIDDIYSRLDILSADVQVDRLITGRLSALNAFVAQTLTKYTEVRASRKLAQQKVNECVKSQSQRYGFCGGDGEHIFSLVQAAPQGLLFLHTVLVPGDFVDVIAIAGLCVNDEIALTLREPGLVLFTHELQNHTATEYFVSSRRMFEPRKPTVSDFVQIESCVVTYVNLTRDQLPDVIPDYIDVNKTLDEILASLPNRTGPSLPLDVFNATYLNLTGEIADLEQRSESLRNTTEELQSLIYNINNTLVDLEWLNRVETYIKWPWWVWLIIFIVLIFVVSLLVFCCISTGCCGCCGCCCACFSGCCRGPRLQPYEVFEKVHVQHHHHHHGSGEGRGSLLTCGDVEENPGPVSAIVLYVLLAAAAHSAFADNFPCSKLTNRTIGNQWNLIETFLLNYSSRLPPNSDVVLGDYFPTVQPWFNCIRNDSNDLYVTLENLKALYWDYATENITWNHRQRLNVVVNGYPYSITVTTTRNFNSAEGAIICICKGSPPTTTTESSLTCNWGSECRLNHKFPICPSNSEANCGNMLYGLQWFADEVVAYLHGASYRISFENQWSGTVTFGDMRATTLEVAGTLVDLWWFNPVYDVSYYRVNNKNGTTVVSNCTDQCASYVANVFTTQPGGFIPSDFSFNNWFLLTNSSTLVSGKLVTKQPLLVNCLWPVPSFEEAASTFCFEGAGFDQCNGAVLNNTVDVIRFNLNFTTNVQSGKGATVFSLNTTGGVTLEISCYTVSDSSFFSYGEIPFGVTDGPRYCYVHYNGTALKYLGTLPPSVKEIAISKWGHFYINGYNFFSTFPIDCISFNLTTGDSDVFWTIAYTSYTEALVQVENTAITKVTYCNSHVNNIKCSQITANLNNGFYPVSSSEVGLVNKSVVLLPSFYTHTIVNITIGLGMKRSGYGQPIASTLSNITLPMQDHNTDVYCIRSDQFSVYVHSTCKSALWDNIFKRNCTDVLDATAVIKTGTCPFSFDKLNNYLTFNKFCLSLSPVGANCKFDVAARTRTNEQVVRSLYVIYEEGDNIVGVPSDNSGVHDLSVLHLDSCTDYNIYGRTGVGIIRQTNRTLLSGLYYTSLSGDLLGFKNVSDGVIYSVTPCDVSAQAAVIDGTIVGAITSINSELLGLTHWTTTPNFYYYSIYNYTNDRTRGTAIDSNDVDCEPVITYSNIGVCKNGAFVFINVTHSDGDVQPISTGNVTIPTNFTISVQVEYIQVYTTPVSIDCSRYVCNGNPRCNKLLTQYVSACQTIEQALAMGARLENMEVDSMLFVSENALKLASVEAFNSSETLDPIYKEWPNIGGSWLESLKYILPSHNSKRKYRSAIEDLLFDKVVTSGLGTVDEDYKRCTGGYDIADLVCAQYYNGIMVLPGGANADKMTMYTASLASGITLGALGGGAVAIPFAVAVQARLNYVALQTDVLNKNQQILASAFNQAIGNITQSFGKVNDAIHQTSRGLATVAKALAKVQDVVNIQGQALSHLTVQLQNNFQAISSSISDIYNRLDELSADAQVDRLITGRLTALNAFVSQTLTRQAEVRASRQLAKDKVNECVRSQSQRFGFCGNGTHLFSLANAAPNGMIFFHTVLLPTAYETVTAWPGICASDGDRTFGLVVKDVQLTLFRNLDDKFYLTPRTMYQPRVATSSDFVQIEGCDVLFVNATVSDLPSIIPDYIDINQTVQDILENFRPNWTVPELTFDIFNATYLNLTGEIDDLEFRSEKLHNTTVELAILIDNINNTLVNLEWLNRIETYVKWPWYVWLLIGLVVIFCIPLLLFCCCSTGCCGCIGCLGSCCHSICSRRQFENYEPVEKVHVHHHHHH。
本发明将得到的培养物离心,得到培养上清液,将所述培养上清液经30kDa超滤膜超滤、镍柱亲和层析,得到蛋白,将所述蛋白与佐剂混合,得到猪流行性腹泻、猪传染性胃肠炎病毒病二联亚单位疫苗。
本发明对所述离心的条件没有特殊限定,采用培养病毒培养物常规离心收集上清液的离心条件即可。本发明对所述超滤和镍柱亲和层析的方法没有特殊限定,采用常规方法即可。
在本发明中,所述蛋白与佐剂的质量优选比为1:1,所述佐剂优选包括ISA 201VG。本发明优选按照水相疫苗的方法来制备疫苗。
下面结合实施例对本发明提供的技术方案进行详细的说明,但是不能把它们理解为对本发明保护范围的限定。
实施例1
PEDV-T2A-TGEV-S序列合成
参考PEDV和TGEV国内流行株的S蛋白基因序列,经密码子优化,合成PEDV-T2A-TGEV-S序列。同时为避免发生同源重组,设计了2组不同核酸序列的GP64信号肽和6组氨酸His标签。PEDV-T2A-TGEV-S序列依次为:一段BV GP64信号肽序列,大小为60个碱基,其核苷酸序列如SEQ ID NO.3所示;PEDV的S蛋白序列,大小为4104个碱基,其碱基序列如SEQ IDNO.4所示;6组氨酸His标签,大小为18个碱基,其碱基序列如SEQ ID NO.5所示;一段自剪切序列T2A,大小为63个碱基,其核苷酸序列如SEQ ID NO.6所示;一段GP64信号肽序列,大小为57个碱基,其核苷酸序列如SEQ ID NO.7所示;TGEV的S蛋白序列,大小为4290个碱基,其碱基序列如SEQ ID NO.8所示;6组氨酸His标签,大小为18个碱基,其碱基序列如SEQ IDNO.9所示;序列的两端分别含有XhoI和KpnI酶切位点。合成后的PEDV-T2A-TGEV-S序列,全长为8625个碱基,如SEQ ID NO.1所示。PEDV-T2A-TGEV-S序列编码的氨基酸序列如SEQ IDNO.2所示。
实施例2
杆状病毒转移载体构建
使用XhoI和KpnI酶切实施例1合成的PEDV-T2A-TGEV-S序列和pFastbacl载体序列,回收酶切后的PEDV-T2A-TGEV-S和pFastbacl序列片段,并进行连接转化克隆,测序验证,构建PEDV-T2A-TGEV-S-pFastbacl转移载体。
实施例3
杆粒制备
将实施例2制得的PEDV-T2A-TGEV-S-pFastbacl转移载体转化感受态细胞DH10Bac,37℃培养后,使用蓝白斑筛选法进行筛选并进行PCR鉴定,获得PEDV-T2A-TGEV-S-rBacmid重组杆粒。杆粒转化和筛选方法参考Invitrogen公司Bac-to-BacTM杆状病毒表达系统用户指南进行操作。
实施例4
培养基配置和蛋白酶抑制剂使用
取45.9gGrace昆虫培养基干粉溶解到900ml超纯水,加入0.35g碳酸氢钠,3.3g水解乳蛋白,3.3g酵母提取物,用1NKOH调节pH至6.2,定容至1000ml,0.22μm滤膜过滤培养基,分装到无菌容器中保存备用。
将丝氨酸蛋白酶抑制剂Aprotinin(500X,工作浓度2μg/ml)、天冬氨酸蛋白酶抑制剂Pepstatin A(1000X,工作浓度1μM)、氨基肽酶抑制剂Bestatin(100X,工作浓度10μM)、半胱氨酸蛋白酶抑制剂E-64(100X,工作浓度10μM)、丝氨酸和半胱氨酸蛋白酶抑制剂Leupeptin(100X,工作浓度100μM),按照稀释比例,在病毒感染细胞24h后,加入细胞培养液中。
实施例5
重组杆状病毒收获
将实施例3获得的PEDV-T2A-TGEV-S-rBacmid重组杆粒利用转染试剂Cellfectin,转染处于对数生长期的Sf9细胞,培养72h后,收获P1代的重组杆状病毒PEDV-T2A-TGEV-S-rBV。将收获的P1代重组杆状病毒继续在Sf9细胞上进行传代培养至P3代,将P3代病毒离心,上清为病毒液,通过噬斑法测定P3代病毒滴度。按照接种量为0.1个MOI,用P3代毒感染SF9细胞,培养96h后,离心,培养上清为病毒液。
实施例6
杆状病毒感染细胞
将实施例5获得的病毒液,按照接种量为2个MOI,感染处于对数生长期的HighFive细胞,感染24h后,在细胞培养液中加入蛋白酶抑制剂,继续培养48h,离心收集培养上清。
实施例7
蛋白纯化及疫苗制备
将实施例6得到的培养上清经30kDa截留分子量切向流超滤膜包超滤到PBS缓冲液中,再通过镍柱亲和层析纯化,纯化的蛋白透析到PBS缓冲液中,制备水相疫苗,与佐剂ISA201VG按照质量比1:1的混合,即为疫苗。
以上所述仅是本发明的优选实施方式,应当指出,对于本技术领域的普通技术人员来说,在不脱离本发明原理的前提下,还可以做出若干改进和润饰,这些改进和润饰也应视为本发明的保护范围。
序列表
<110> 金河佑本生物制品有限公司
杭州佑本动物疫苗有限公司
<120> 一种猪流行性腹泻、猪传染性胃肠炎病毒病二联亚单位疫苗的制备方法
<160> 9
<170> SIPOSequenceListing 1.0
<210> 1
<211> 8625
<212> DNA
<213> 人工序列(Artificial Sequence)
<400> 1
ctcgagatgg tgtccgctat tgtgttatac gtcctgttag ctgctgccgc gcacagtgcc 60
tttgcgttgc ctcaagacgt tacacgatgc tctgcaaaca caaacttccg acgattcttc 120
tcaaaattca acgtgcaggc accagcagtt gtagttctag gaggatacct gccaatcgga 180
gagaatcaag gagttaactc tacatggtac tgcgcaggac agcatccaac agcatccggc 240
gttcatggta tattcgtttc tcatatccga ggaggacatg gattcgaaat cggaatctct 300
caggaaccat tcgatccatc tggataccag ctttaccttc ataaagcaac aaacggaaac 360
acaaacgcaa cagcacgact tcgaatctgc cagttcccat ctatcaagac cttaggacca 420
acagcaaaca acgatgttac aacaggacga aactgcttat tcaacaaggc cataccagca 480
catatgtctg aacattctgt tgttggaatc acatgggata acgatcgagt tacggtattc 540
agcgataaga tatactactt ctacttcaag aatgactggt ctcgggtagc tactaaatgc 600
tataactctg gaggatgcgc aatgcagtac gtttacgaac caacatacta catgcttaat 660
gtcacctccg ccggcgaaga tggaatctct taccagccat gcacagcaaa ctgcatcgga 720
tactctgcta atgtctttgc gaccgaacca aacggacata tcccagaagg attcagcttc 780
aacaactggt tcttgcttag taatgattcc acgttggtgc acgggaaggt ggtgtcgaat 840
cagccactac tagtgaattg tttattggcg atcccaaaga tatatggact tggacagttc 900
ttcagcttca atcaaactat agacggcgtg tgtaatggtg ctgccgtgca gcgagcacca 960
gaagcacttc gattcaacat caacgataca tctgttatcc ttgcagaagg atctatcgtt 1020
cttcatacag cacttggaac aaacttcagc ttcgtttgct ctaactcttc tgatccacat 1080
cttgcaacat tcgcaatccc acttggagca atccaggttc catactactg cttccttaaa 1140
gttgatacat acaactctac agtttacaaa ttcctgtcag tgttgcctcc tacggtgaga 1200
gagattgtca tcacaaagta tggcgatgtt tacgttaacg gattcggata ccttcatctt 1260
ggacttcttg atgcagttac aatcaacttc acaggacatg gaacagatga tgatgtttct 1320
ggattctgga cgattgcaag caccaacttt gtcgatgcgc taatcgaagt tcagggcacg 1380
gctattcaaa ggatccttta ctgcgatgat ccagtttctc agcttaaatg ctcacaggtc 1440
gctttcgatc ttgatgatgg cttctaccct atcagctctc gaaaccttct ttctcatgaa 1500
caacccatta gtttcgtggc cctgccgtca tttaatgacc attctttcgt gaacattacg 1560
gtatcagcat ctttcggagg acattctgga gcaaacctta tcgcatctga tacaacaatc 1620
aacggattca gtagtttctg cgtggataca cgacagttta ctatcagctt attctataat 1680
gtaacaaact cgtatggcta cgtttctaaa tctcaggatt ctaactgccc attcacactt 1740
cagtctgtta acgattacct ttctttcagt aaattctgcg tgtctacctc actcttggcc 1800
agtgcttgta ccatcgatct ctttggttac ccagaattcg gatctggagt taaattcaca 1860
tctctttact tccagttcac aaagggtgag ttgattaccg gtactagcaa accacttgaa 1920
ggtgttacgg acgtcagctt catgacctta gacgtctgta caaagtatac tatttatgga 1980
ttcaaaggag aaggaatcat cacattaaca aacagctcgt tcttagcagg agtatattat 2040
acttcagaca gtggacaact gttggcgttc aagaatgtaa cgagtggcgc tgtatatagc 2100
gtaacgccgt gcagcttctc cgagcaggca gcatacgttg atgatgatat agtgggtgtc 2160
atttcatctc tttcttcttc tacattcaac tctacacgag aacttccagg attcttctac 2220
cacagcaatg acggtagcaa ttgtactgag ccggttcttg tttatagtaa tataggcgta 2280
tgcaagagcg gttctatcgg atacgttcca tctcagtctg gacaggttaa gatagcgccc 2340
accgttacag gaaacatctc tataccgaca aactttagca tgagtatccg aacagaatac 2400
cttcagcttt acaacactcc tgtgtccgta gactgcgcaa catacgtgtg caacggtaac 2460
agtagatgca aacagctgtt aacccaatat actgcggcat gcaagaccat tgaatctgct 2520
ctccaactct ccgcgcggct ggagtcggtc gaagttaact ctatgcttac aatctctgaa 2580
gaagctttac aattagcgac cataagtagc tttaatggag atggttataa tttcaccaac 2640
gttcttggag tttctgttta cgatccagca tctggacgag ttgttcagaa acgatctttc 2700
attgaggacc tgctctttaa taaggtcgtt acgaatggtc tcggtactgt agacgaggac 2760
tataagagat gtagtaacgg acgatctgtt gcggacttgg tatgtgctca atattattcc 2820
ggtgttatgg tcttgcccgg tgtagtcgat gcagagaagt tgcacatgta ttctgcatct 2880
cttatcggag gaatggtgtt gggtgggttt acctctgcag cagcacttcc attctcttac 2940
gccgtacaag ctcgtttgaa ttatcttgcg ctacaaactg atgttctcca gcggaaccag 3000
caactgctcg cggagtcgtt taatagtgcc attgggtcta tcacatctgc attcgaatcc 3060
gtcaaggagg ctatatctca gacatctaaa ggacttaaca cagttgcaca tgcacttact 3120
aaggtccaag aagttgttaa ctctcaggga gcagcactta cacagctgac ggtgcaatta 3180
caacacaatt tccaggcgat aagcagtagt atagacgaca tctactctcg acttgatatc 3240
ctctcagctg acgtgcaggt agaccgccta ataactggac gacttagcgc actgaatgct 3300
ttcgtagcac agacgttaac caagtataca gaagttcgtg cttcccgtaa acttgctcag 3360
cagaaggtca acgaatgcgt aaagagtcag tcgcaacgct atggattctg cggtggagac 3420
ggcgaacata tcttctctct tgttcaggca gcaccacagg gactcttatt tctgcacact 3480
gtcctagtac cgggagactt tgtcgatgta atcgctatag caggactttg cgttaacgat 3540
gaaatcgcac ttacacttcg agaaccagga cttgttctgt ttactcatga acttcagaac 3600
catacagcaa cagaatactt cgtttcttct cgacgaatgt tcgaaccacg aaagccgacc 3660
gtcagtgact ttgtgcaaat tgagtcctgt gttgttacat acgttaacct tacacgagat 3720
cagcttccag atgttatacc ggattacatc gatgtaaaca agaccttaga tgaaattctc 3780
gcttcgctcc cgaaccgaac aggaccatct cttcctctag acgtgttcaa cgcaacgtat 3840
ttaaatctca cgggtgagat cgcagatctt gaacaacgat ctgaatctct tcgaaacaca 3900
acagaagaac ttcagtctct tatctacaat ataaataata cattagtgga tctggaatgg 3960
ctcaatcggg tcgagacata catcaagtgg ccgtggtggg tgtggcttat catcttcatc 4020
gttcttatct tcgttgtatc cctgctagta ttctgttgta tatctaccgg atgctgcggt 4080
tgctgcggtt gctgctgtgc gtgcttctct ggatgctgcc gaggaccacg acttcagcca 4140
tacgaagtct ttgagaaagt tcatgtccaa catcaccacc accaccacgg ctcaggagaa 4200
ggacgaggat ctcttcttac atgcggagat gttgaagaga atcccggacc agtctccgcc 4260
atagtattgt acgtacttct cgccgccgct gcccactcag cctttgccga caatttccca 4320
tgctctaaac ttactaatag gacgataggc aaccagtgga accttatcga aacattcctt 4380
cttaactact cttctcgact tccaccaaac tctgatgtgg tgttgggcga ctatttccca 4440
acagttcagc catggttcaa ctgcatccga aacgacagca atgacttgta tgtgaccctg 4500
gagaatctaa aggcgttata ctgggattac gcaacagaga atattacatg gaaccatcga 4560
cagcgactta acgttgttgt taacggatac ccatactcta tcacagttac aacaacacga 4620
aactttaata gtgctgaggg tgcaatcatc tgcatctgca aaggatctcc accaacaaca 4680
acaacagaat cttctcttac atgcaactgg ggctctgagt gccgacttaa ccataaattc 4740
ccaatctgcc catctaactc tgaagcaaac tgcggaaaca tgctttacgg acttcagtgg 4800
ttcgcagatg aagttgttgc ataccttcat ggagcatctt accgaatctc tttcgagaat 4860
caatggtctg gaacagttac attcggagat atgcgagcaa caacacttga agttgcagga 4920
acgctcgtcg acctatggtg gttcaaccca gtttacgatg tttcttacta ccgagttaac 4980
aacaagaatg ggacaacagt agtcagtaat tgtaccgatc agtgtgcatc ttacgttgcc 5040
aatgtgttta caacgcagcc aggaggattc atcccatctg atttttcttt taataattgg 5100
tttttgctta caaatagctc cacactggtg tcgggcaaat tggtcacaaa gcagcctcta 5160
ctcgtcaatt gtctctggcc tgttccatct ttcgaagaag cagcatctac attctgcttc 5220
gaaggagcag gattcgatca gtgcaacgga gcggtgttaa acaacacagt ggacgtaata 5280
cgctttaacc ttaacttcac aacaaacgtt cagtctggaa agggcgctac ggtattctca 5340
ctcaatacaa caggaggagt cacgctagag atttcatgct acacagtatc ggatagttca 5400
ttcttctcct acggagagat tccattcggc gtaaccgacg gccctcgata ctgctacgtt 5460
cattacaacg gaacagcact taaatacctt ggaacacttc caccatccgt aaaggagatt 5520
gctatctcta aatggggcca cttctatatt aacggctata atttcttctc aacctttccc 5580
atcgattgca tatcatttaa tctgacgaca ggagattctg atgtattctg gaccatagcg 5640
tatacgtctt acacagaagc attggtgcaa gttgagaata ccgcaatcac aaaggtgacc 5700
tactgcaact ctcatgttaa caacatcaaa tgctcccaga taacagcaaa ccttaacaac 5760
gggttctacc ctgtaagctc ttctgaagtc gggctagtaa ataagtctgt tgtgttgcta 5820
cccagcttct atactcatac aattgtgaat attaccattg gccttggaat gaaacgatct 5880
ggatacggac agcctatagc ttcgacttta agtaacatca cacttccaat gcaggatcat 5940
aacacagatg tttactgcat ccgatctgat cagttctctg tttacgttca ttctacatgc 6000
aaatctgcac tttgggataa catcttcaaa cgaaattgta cagatgttct agacgcgaca 6060
gcagttatca agactgggac atgcccattc tctttcgata aacttaacaa ctaccttaca 6120
ttcaacaaat tctgcctttc tctttctcca gttggagcaa actgcaaatt cgatgttgca 6180
gcacgaacac gaacaaacga acaggttgtt cgatctcttt acgttatcta cgaagaagga 6240
gataacattg tcggtgtgcc gtcagataac tcaggcgttc atgacttgag tgtgctacac 6300
ttagattctt gcacagatta caacatctac ggacgaacag gagttggaat catccgacag 6360
acgaatcgga ctctactgtc tggattatat tatacgtcat taagcggaga tcttcttgga 6420
tttaagaatg tgtcggacgg agttatctat tcggtgactc cgtgcgacgt atctgcacag 6480
gcagcagtta tcgatggaac aatcgttgga gcaatcacat ctatcaactc tgaacttctt 6540
ggacttacac attggacaac aacaccaaac ttctactact actctatcta caactacaca 6600
aacgatcgaa cacgagggac ggctatagac agtaacgatg tcgattgcga accagttatc 6660
acatattcga atataggcgt gtgtaagaat ggcgctttcg tcttcataaa cgttacacat 6720
agtgacggcg acgtccagcc catttctact gggaatgtaa caattcctac caatttcact 6780
atttcggtgc aagtcgaata catccaggtt tacacaacgc cggtatccat tgactgctct 6840
cgatacgtat gcaacggaaa ccctcggtgc aataagctgt tgacacaata tgtgtccgca 6900
tgccaaacca tagagcaagc acttgcaatg ggagctcgac tggagaatat ggaggttgat 6960
tctatgctgt ttgtatctga gaatgcgctt aaacttgcat ctgttgaagc attcaactct 7020
tctgaaacac ttgatccaat ctacaaagaa tggccaaaca tcggaggatc ttggcttgaa 7080
tctcttaaat acatccttcc atctcataac tctaaacgaa agtatagatc tgcaatagag 7140
gacttactat ttgacaaagt ggttacatct gggttgggca ccgtggacga ggactataag 7200
cgctgtacag gtgggtatga tatagccgat cttgtgtgcg cgcaatatta taatggtatc 7260
atggtcctcc cgggaggggc taatgcagat aagatgacga tgtacacagc atctcttgca 7320
tctggaatca cacttggagc acttggagga ggagcagttg caatcccatt cgcagttgct 7380
gtgcaagcga gactcaatta tgtggcgtta caaaccgatg ttctaaacaa gaatcaacag 7440
atattagcat ctgcattcaa tcaggcaatc ggaaacatca cacagtcttt cggaaaggtg 7500
aatgatgcaa tccatcagac atcccgagga cttgcaacag ttgcaaaggc tttagcgaaa 7560
gttcaggacg tagttaacat ccagggacag gcactctcac acctgacagt tcaactgcag 7620
aacaacttcc aggcgattag ctcatctata tcagacatct acaaccgact tgatgaatta 7680
tccgctgacg ctcaggtgga cagactaatc acgggacggc taaccgcgct caatgcgttt 7740
gtaagtcaga ctctcacgcg ccaagccgag gtgagggcga gtcggcaatt ggcaaaggac 7800
aaagtgaacg aatgcgttcg atctcaatcc caacgtttcg ggttctgtgg aaatgggaca 7860
cacttgttct ctttagccaa cgcagcacca aacggaatga tcttcttcca caccgtccta 7920
ctgcccaccg cgtacgaaac agttacagca tggccaggaa tctgcgcatc ggacggcgac 7980
agaacctttg gtctagtcgt gaaggacgtt cagcttacat tatttcgtaa ccttgatgat 8040
aaattctacc ttacaccacg aacaatgtac cagccacgcg tagcgactag ttcagatttc 8100
gttcagatag agggctgtga tgttctgttt gtcaacgcca cggtttcaga tttgccatct 8160
atcatccctg actatataga tattaaccag acagttcagg atatccttga gaatttccgt 8220
cccaactgga cagttccaga acttacattc gatatcttta atgccaccta tctgaattta 8280
accggtgaaa tagacgacct tgaattccga tctgagaagc ttcacaatac gacagttgaa 8340
cttgcaatcc ttatcgataa tattaataat accttagtga atttagagtg gctgaatcgg 8400
atagagacat acgttaagtg gccctggtat gtctggcttc ttattgggtt ggtcgtaata 8460
ttctgtatac cacttcttct cttctgctgt tgcagcactg gttgctgcgg gtgcatcgga 8520
tgccttggat cttgctgcca ttctatctgc tctcgacgac aatttgagaa ttatgaacca 8580
gttgagaagg ttcacgtgca ccaccatcat catcattgag gtacc 8625
<210> 2
<211> 2870
<212> PRT
<213> 人工序列(Artificial Sequence)
<400> 2
Met Val Ser Ala Ile Val Leu Tyr Val Leu Leu Ala Ala Ala Ala His
1 5 10 15
Ser Ala Phe Ala Leu Pro Gln Asp Val Thr Arg Cys Ser Ala Asn Thr
20 25 30
Asn Phe Arg Arg Phe Phe Ser Lys Phe Asn Val Gln Ala Pro Ala Val
35 40 45
Val Val Leu Gly Gly Tyr Leu Pro Ile Gly Glu Asn Gln Gly Val Asn
50 55 60
Ser Thr Trp Tyr Cys Ala Gly Gln His Pro Thr Ala Ser Gly Val His
65 70 75 80
Gly Ile Phe Val Ser His Ile Arg Gly Gly His Gly Phe Glu Ile Gly
85 90 95
Ile Ser Gln Glu Pro Phe Asp Pro Ser Gly Tyr Gln Leu Tyr Leu His
100 105 110
Lys Ala Thr Asn Gly Asn Thr Asn Ala Thr Ala Arg Leu Arg Ile Cys
115 120 125
Gln Phe Pro Ser Ile Lys Thr Leu Gly Pro Thr Ala Asn Asn Asp Val
130 135 140
Thr Thr Gly Arg Asn Cys Leu Phe Asn Lys Ala Ile Pro Ala His Met
145 150 155 160
Ser Glu His Ser Val Val Gly Ile Thr Trp Asp Asn Asp Arg Val Thr
165 170 175
Val Phe Ser Asp Lys Ile Tyr Tyr Phe Tyr Phe Lys Asn Asp Trp Ser
180 185 190
Arg Val Ala Thr Lys Cys Tyr Asn Ser Gly Gly Cys Ala Met Gln Tyr
195 200 205
Val Tyr Glu Pro Thr Tyr Tyr Met Leu Asn Val Thr Ser Ala Gly Glu
210 215 220
Asp Gly Ile Ser Tyr Gln Pro Cys Thr Ala Asn Cys Ile Gly Tyr Ser
225 230 235 240
Ala Asn Val Phe Ala Thr Glu Pro Asn Gly His Ile Pro Glu Gly Phe
245 250 255
Ser Phe Asn Asn Trp Phe Leu Leu Ser Asn Asp Ser Thr Leu Val His
260 265 270
Gly Lys Val Val Ser Asn Gln Pro Leu Leu Val Asn Cys Leu Leu Ala
275 280 285
Ile Pro Lys Ile Tyr Gly Leu Gly Gln Phe Phe Ser Phe Asn Gln Thr
290 295 300
Ile Asp Gly Val Cys Asn Gly Ala Ala Val Gln Arg Ala Pro Glu Ala
305 310 315 320
Leu Arg Phe Asn Ile Asn Asp Thr Ser Val Ile Leu Ala Glu Gly Ser
325 330 335
Ile Val Leu His Thr Ala Leu Gly Thr Asn Phe Ser Phe Val Cys Ser
340 345 350
Asn Ser Ser Asp Pro His Leu Ala Thr Phe Ala Ile Pro Leu Gly Ala
355 360 365
Ile Gln Val Pro Tyr Tyr Cys Phe Leu Lys Val Asp Thr Tyr Asn Ser
370 375 380
Thr Val Tyr Lys Phe Leu Ser Val Leu Pro Pro Thr Val Arg Glu Ile
385 390 395 400
Val Ile Thr Lys Tyr Gly Asp Val Tyr Val Asn Gly Phe Gly Tyr Leu
405 410 415
His Leu Gly Leu Leu Asp Ala Val Thr Ile Asn Phe Thr Gly His Gly
420 425 430
Thr Asp Asp Asp Val Ser Gly Phe Trp Thr Ile Ala Ser Thr Asn Phe
435 440 445
Val Asp Ala Leu Ile Glu Val Gln Gly Thr Ala Ile Gln Arg Ile Leu
450 455 460
Tyr Cys Asp Asp Pro Val Ser Gln Leu Lys Cys Ser Gln Val Ala Phe
465 470 475 480
Asp Leu Asp Asp Gly Phe Tyr Pro Ile Ser Ser Arg Asn Leu Leu Ser
485 490 495
His Glu Gln Pro Ile Ser Phe Val Ala Leu Pro Ser Phe Asn Asp His
500 505 510
Ser Phe Val Asn Ile Thr Val Ser Ala Ser Phe Gly Gly His Ser Gly
515 520 525
Ala Asn Leu Ile Ala Ser Asp Thr Thr Ile Asn Gly Phe Ser Ser Phe
530 535 540
Cys Val Asp Thr Arg Gln Phe Thr Ile Ser Leu Phe Tyr Asn Val Thr
545 550 555 560
Asn Ser Tyr Gly Tyr Val Ser Lys Ser Gln Asp Ser Asn Cys Pro Phe
565 570 575
Thr Leu Gln Ser Val Asn Asp Tyr Leu Ser Phe Ser Lys Phe Cys Val
580 585 590
Ser Thr Ser Leu Leu Ala Ser Ala Cys Thr Ile Asp Leu Phe Gly Tyr
595 600 605
Pro Glu Phe Gly Ser Gly Val Lys Phe Thr Ser Leu Tyr Phe Gln Phe
610 615 620
Thr Lys Gly Glu Leu Ile Thr Gly Thr Ser Lys Pro Leu Glu Gly Val
625 630 635 640
Thr Asp Val Ser Phe Met Thr Leu Asp Val Cys Thr Lys Tyr Thr Ile
645 650 655
Tyr Gly Phe Lys Gly Glu Gly Ile Ile Thr Leu Thr Asn Ser Ser Phe
660 665 670
Leu Ala Gly Val Tyr Tyr Thr Ser Asp Ser Gly Gln Leu Leu Ala Phe
675 680 685
Lys Asn Val Thr Ser Gly Ala Val Tyr Ser Val Thr Pro Cys Ser Phe
690 695 700
Ser Glu Gln Ala Ala Tyr Val Asp Asp Asp Ile Val Gly Val Ile Ser
705 710 715 720
Ser Leu Ser Ser Ser Thr Phe Asn Ser Thr Arg Glu Leu Pro Gly Phe
725 730 735
Phe Tyr His Ser Asn Asp Gly Ser Asn Cys Thr Glu Pro Val Leu Val
740 745 750
Tyr Ser Asn Ile Gly Val Cys Lys Ser Gly Ser Ile Gly Tyr Val Pro
755 760 765
Ser Gln Ser Gly Gln Val Lys Ile Ala Pro Thr Val Thr Gly Asn Ile
770 775 780
Ser Ile Pro Thr Asn Phe Ser Met Ser Ile Arg Thr Glu Tyr Leu Gln
785 790 795 800
Leu Tyr Asn Thr Pro Val Ser Val Asp Cys Ala Thr Tyr Val Cys Asn
805 810 815
Gly Asn Ser Arg Cys Lys Gln Leu Leu Thr Gln Tyr Thr Ala Ala Cys
820 825 830
Lys Thr Ile Glu Ser Ala Leu Gln Leu Ser Ala Arg Leu Glu Ser Val
835 840 845
Glu Val Asn Ser Met Leu Thr Ile Ser Glu Glu Ala Leu Gln Leu Ala
850 855 860
Thr Ile Ser Ser Phe Asn Gly Asp Gly Tyr Asn Phe Thr Asn Val Leu
865 870 875 880
Gly Val Ser Val Tyr Asp Pro Ala Ser Gly Arg Val Val Gln Lys Arg
885 890 895
Ser Phe Ile Glu Asp Leu Leu Phe Asn Lys Val Val Thr Asn Gly Leu
900 905 910
Gly Thr Val Asp Glu Asp Tyr Lys Arg Cys Ser Asn Gly Arg Ser Val
915 920 925
Ala Asp Leu Val Cys Ala Gln Tyr Tyr Ser Gly Val Met Val Leu Pro
930 935 940
Gly Val Val Asp Ala Glu Lys Leu His Met Tyr Ser Ala Ser Leu Ile
945 950 955 960
Gly Gly Met Val Leu Gly Gly Phe Thr Ser Ala Ala Ala Leu Pro Phe
965 970 975
Ser Tyr Ala Val Gln Ala Arg Leu Asn Tyr Leu Ala Leu Gln Thr Asp
980 985 990
Val Leu Gln Arg Asn Gln Gln Leu Leu Ala Glu Ser Phe Asn Ser Ala
995 1000 1005
Ile Gly Ser Ile Thr Ser Ala Phe Glu Ser Val Lys Glu Ala Ile Ser
1010 1015 1020
Gln Thr Ser Lys Gly Leu Asn Thr Val Ala His Ala Leu Thr Lys Val
1025 1030 1035 1040
Gln Glu Val Val Asn Ser Gln Gly Ala Ala Leu Thr Gln Leu Thr Val
1045 1050 1055
Gln Leu Gln His Asn Phe Gln Ala Ile Ser Ser Ser Ile Asp Asp Ile
1060 1065 1070
Tyr Ser Arg Leu Asp Ile Leu Ser Ala Asp Val Gln Val Asp Arg Leu
1075 1080 1085
Ile Thr Gly Arg Leu Ser Ala Leu Asn Ala Phe Val Ala Gln Thr Leu
1090 1095 1100
Thr Lys Tyr Thr Glu Val Arg Ala Ser Arg Lys Leu Ala Gln Gln Lys
1105 1110 1115 1120
Val Asn Glu Cys Val Lys Ser Gln Ser Gln Arg Tyr Gly Phe Cys Gly
1125 1130 1135
Gly Asp Gly Glu His Ile Phe Ser Leu Val Gln Ala Ala Pro Gln Gly
1140 1145 1150
Leu Leu Phe Leu His Thr Val Leu Val Pro Gly Asp Phe Val Asp Val
1155 1160 1165
Ile Ala Ile Ala Gly Leu Cys Val Asn Asp Glu Ile Ala Leu Thr Leu
1170 1175 1180
Arg Glu Pro Gly Leu Val Leu Phe Thr His Glu Leu Gln Asn His Thr
1185 1190 1195 1200
Ala Thr Glu Tyr Phe Val Ser Ser Arg Arg Met Phe Glu Pro Arg Lys
1205 1210 1215
Pro Thr Val Ser Asp Phe Val Gln Ile Glu Ser Cys Val Val Thr Tyr
1220 1225 1230
Val Asn Leu Thr Arg Asp Gln Leu Pro Asp Val Ile Pro Asp Tyr Ile
1235 1240 1245
Asp Val Asn Lys Thr Leu Asp Glu Ile Leu Ala Ser Leu Pro Asn Arg
1250 1255 1260
Thr Gly Pro Ser Leu Pro Leu Asp Val Phe Asn Ala Thr Tyr Leu Asn
1265 1270 1275 1280
Leu Thr Gly Glu Ile Ala Asp Leu Glu Gln Arg Ser Glu Ser Leu Arg
1285 1290 1295
Asn Thr Thr Glu Glu Leu Gln Ser Leu Ile Tyr Asn Ile Asn Asn Thr
1300 1305 1310
Leu Val Asp Leu Glu Trp Leu Asn Arg Val Glu Thr Tyr Ile Lys Trp
1315 1320 1325
Pro Trp Trp Val Trp Leu Ile Ile Phe Ile Val Leu Ile Phe Val Val
1330 1335 1340
Ser Leu Leu Val Phe Cys Cys Ile Ser Thr Gly Cys Cys Gly Cys Cys
1345 1350 1355 1360
Gly Cys Cys Cys Ala Cys Phe Ser Gly Cys Cys Arg Gly Pro Arg Leu
1365 1370 1375
Gln Pro Tyr Glu Val Phe Glu Lys Val His Val Gln His His His His
1380 1385 1390
His His Gly Ser Gly Glu Gly Arg Gly Ser Leu Leu Thr Cys Gly Asp
1395 1400 1405
Val Glu Glu Asn Pro Gly Pro Val Ser Ala Ile Val Leu Tyr Val Leu
1410 1415 1420
Leu Ala Ala Ala Ala His Ser Ala Phe Ala Asp Asn Phe Pro Cys Ser
1425 1430 1435 1440
Lys Leu Thr Asn Arg Thr Ile Gly Asn Gln Trp Asn Leu Ile Glu Thr
1445 1450 1455
Phe Leu Leu Asn Tyr Ser Ser Arg Leu Pro Pro Asn Ser Asp Val Val
1460 1465 1470
Leu Gly Asp Tyr Phe Pro Thr Val Gln Pro Trp Phe Asn Cys Ile Arg
1475 1480 1485
Asn Asp Ser Asn Asp Leu Tyr Val Thr Leu Glu Asn Leu Lys Ala Leu
1490 1495 1500
Tyr Trp Asp Tyr Ala Thr Glu Asn Ile Thr Trp Asn His Arg Gln Arg
1505 1510 1515 1520
Leu Asn Val Val Val Asn Gly Tyr Pro Tyr Ser Ile Thr Val Thr Thr
1525 1530 1535
Thr Arg Asn Phe Asn Ser Ala Glu Gly Ala Ile Ile Cys Ile Cys Lys
1540 1545 1550
Gly Ser Pro Pro Thr Thr Thr Thr Glu Ser Ser Leu Thr Cys Asn Trp
1555 1560 1565
Gly Ser Glu Cys Arg Leu Asn His Lys Phe Pro Ile Cys Pro Ser Asn
1570 1575 1580
Ser Glu Ala Asn Cys Gly Asn Met Leu Tyr Gly Leu Gln Trp Phe Ala
1585 1590 1595 1600
Asp Glu Val Val Ala Tyr Leu His Gly Ala Ser Tyr Arg Ile Ser Phe
1605 1610 1615
Glu Asn Gln Trp Ser Gly Thr Val Thr Phe Gly Asp Met Arg Ala Thr
1620 1625 1630
Thr Leu Glu Val Ala Gly Thr Leu Val Asp Leu Trp Trp Phe Asn Pro
1635 1640 1645
Val Tyr Asp Val Ser Tyr Tyr Arg Val Asn Asn Lys Asn Gly Thr Thr
1650 1655 1660
Val Val Ser Asn Cys Thr Asp Gln Cys Ala Ser Tyr Val Ala Asn Val
1665 1670 1675 1680
Phe Thr Thr Gln Pro Gly Gly Phe Ile Pro Ser Asp Phe Ser Phe Asn
1685 1690 1695
Asn Trp Phe Leu Leu Thr Asn Ser Ser Thr Leu Val Ser Gly Lys Leu
1700 1705 1710
Val Thr Lys Gln Pro Leu Leu Val Asn Cys Leu Trp Pro Val Pro Ser
1715 1720 1725
Phe Glu Glu Ala Ala Ser Thr Phe Cys Phe Glu Gly Ala Gly Phe Asp
1730 1735 1740
Gln Cys Asn Gly Ala Val Leu Asn Asn Thr Val Asp Val Ile Arg Phe
1745 1750 1755 1760
Asn Leu Asn Phe Thr Thr Asn Val Gln Ser Gly Lys Gly Ala Thr Val
1765 1770 1775
Phe Ser Leu Asn Thr Thr Gly Gly Val Thr Leu Glu Ile Ser Cys Tyr
1780 1785 1790
Thr Val Ser Asp Ser Ser Phe Phe Ser Tyr Gly Glu Ile Pro Phe Gly
1795 1800 1805
Val Thr Asp Gly Pro Arg Tyr Cys Tyr Val His Tyr Asn Gly Thr Ala
1810 1815 1820
Leu Lys Tyr Leu Gly Thr Leu Pro Pro Ser Val Lys Glu Ile Ala Ile
1825 1830 1835 1840
Ser Lys Trp Gly His Phe Tyr Ile Asn Gly Tyr Asn Phe Phe Ser Thr
1845 1850 1855
Phe Pro Ile Asp Cys Ile Ser Phe Asn Leu Thr Thr Gly Asp Ser Asp
1860 1865 1870
Val Phe Trp Thr Ile Ala Tyr Thr Ser Tyr Thr Glu Ala Leu Val Gln
1875 1880 1885
Val Glu Asn Thr Ala Ile Thr Lys Val Thr Tyr Cys Asn Ser His Val
1890 1895 1900
Asn Asn Ile Lys Cys Ser Gln Ile Thr Ala Asn Leu Asn Asn Gly Phe
1905 1910 1915 1920
Tyr Pro Val Ser Ser Ser Glu Val Gly Leu Val Asn Lys Ser Val Val
1925 1930 1935
Leu Leu Pro Ser Phe Tyr Thr His Thr Ile Val Asn Ile Thr Ile Gly
1940 1945 1950
Leu Gly Met Lys Arg Ser Gly Tyr Gly Gln Pro Ile Ala Ser Thr Leu
1955 1960 1965
Ser Asn Ile Thr Leu Pro Met Gln Asp His Asn Thr Asp Val Tyr Cys
1970 1975 1980
Ile Arg Ser Asp Gln Phe Ser Val Tyr Val His Ser Thr Cys Lys Ser
1985 1990 1995 2000
Ala Leu Trp Asp Asn Ile Phe Lys Arg Asn Cys Thr Asp Val Leu Asp
2005 2010 2015
Ala Thr Ala Val Ile Lys Thr Gly Thr Cys Pro Phe Ser Phe Asp Lys
2020 2025 2030
Leu Asn Asn Tyr Leu Thr Phe Asn Lys Phe Cys Leu Ser Leu Ser Pro
2035 2040 2045
Val Gly Ala Asn Cys Lys Phe Asp Val Ala Ala Arg Thr Arg Thr Asn
2050 2055 2060
Glu Gln Val Val Arg Ser Leu Tyr Val Ile Tyr Glu Glu Gly Asp Asn
2065 2070 2075 2080
Ile Val Gly Val Pro Ser Asp Asn Ser Gly Val His Asp Leu Ser Val
2085 2090 2095
Leu His Leu Asp Ser Cys Thr Asp Tyr Asn Ile Tyr Gly Arg Thr Gly
2100 2105 2110
Val Gly Ile Ile Arg Gln Thr Asn Arg Thr Leu Leu Ser Gly Leu Tyr
2115 2120 2125
Tyr Thr Ser Leu Ser Gly Asp Leu Leu Gly Phe Lys Asn Val Ser Asp
2130 2135 2140
Gly Val Ile Tyr Ser Val Thr Pro Cys Asp Val Ser Ala Gln Ala Ala
2145 2150 2155 2160
Val Ile Asp Gly Thr Ile Val Gly Ala Ile Thr Ser Ile Asn Ser Glu
2165 2170 2175
Leu Leu Gly Leu Thr His Trp Thr Thr Thr Pro Asn Phe Tyr Tyr Tyr
2180 2185 2190
Ser Ile Tyr Asn Tyr Thr Asn Asp Arg Thr Arg Gly Thr Ala Ile Asp
2195 2200 2205
Ser Asn Asp Val Asp Cys Glu Pro Val Ile Thr Tyr Ser Asn Ile Gly
2210 2215 2220
Val Cys Lys Asn Gly Ala Phe Val Phe Ile Asn Val Thr His Ser Asp
2225 2230 2235 2240
Gly Asp Val Gln Pro Ile Ser Thr Gly Asn Val Thr Ile Pro Thr Asn
2245 2250 2255
Phe Thr Ile Ser Val Gln Val Glu Tyr Ile Gln Val Tyr Thr Thr Pro
2260 2265 2270
Val Ser Ile Asp Cys Ser Arg Tyr Val Cys Asn Gly Asn Pro Arg Cys
2275 2280 2285
Asn Lys Leu Leu Thr Gln Tyr Val Ser Ala Cys Gln Thr Ile Glu Gln
2290 2295 2300
Ala Leu Ala Met Gly Ala Arg Leu Glu Asn Met Glu Val Asp Ser Met
2305 2310 2315 2320
Leu Phe Val Ser Glu Asn Ala Leu Lys Leu Ala Ser Val Glu Ala Phe
2325 2330 2335
Asn Ser Ser Glu Thr Leu Asp Pro Ile Tyr Lys Glu Trp Pro Asn Ile
2340 2345 2350
Gly Gly Ser Trp Leu Glu Ser Leu Lys Tyr Ile Leu Pro Ser His Asn
2355 2360 2365
Ser Lys Arg Lys Tyr Arg Ser Ala Ile Glu Asp Leu Leu Phe Asp Lys
2370 2375 2380
Val Val Thr Ser Gly Leu Gly Thr Val Asp Glu Asp Tyr Lys Arg Cys
2385 2390 2395 2400
Thr Gly Gly Tyr Asp Ile Ala Asp Leu Val Cys Ala Gln Tyr Tyr Asn
2405 2410 2415
Gly Ile Met Val Leu Pro Gly Gly Ala Asn Ala Asp Lys Met Thr Met
2420 2425 2430
Tyr Thr Ala Ser Leu Ala Ser Gly Ile Thr Leu Gly Ala Leu Gly Gly
2435 2440 2445
Gly Ala Val Ala Ile Pro Phe Ala Val Ala Val Gln Ala Arg Leu Asn
2450 2455 2460
Tyr Val Ala Leu Gln Thr Asp Val Leu Asn Lys Asn Gln Gln Ile Leu
2465 2470 2475 2480
Ala Ser Ala Phe Asn Gln Ala Ile Gly Asn Ile Thr Gln Ser Phe Gly
2485 2490 2495
Lys Val Asn Asp Ala Ile His Gln Thr Ser Arg Gly Leu Ala Thr Val
2500 2505 2510
Ala Lys Ala Leu Ala Lys Val Gln Asp Val Val Asn Ile Gln Gly Gln
2515 2520 2525
Ala Leu Ser His Leu Thr Val Gln Leu Gln Asn Asn Phe Gln Ala Ile
2530 2535 2540
Ser Ser Ser Ile Ser Asp Ile Tyr Asn Arg Leu Asp Glu Leu Ser Ala
2545 2550 2555 2560
Asp Ala Gln Val Asp Arg Leu Ile Thr Gly Arg Leu Thr Ala Leu Asn
2565 2570 2575
Ala Phe Val Ser Gln Thr Leu Thr Arg Gln Ala Glu Val Arg Ala Ser
2580 2585 2590
Arg Gln Leu Ala Lys Asp Lys Val Asn Glu Cys Val Arg Ser Gln Ser
2595 2600 2605
Gln Arg Phe Gly Phe Cys Gly Asn Gly Thr His Leu Phe Ser Leu Ala
2610 2615 2620
Asn Ala Ala Pro Asn Gly Met Ile Phe Phe His Thr Val Leu Leu Pro
2625 2630 2635 2640
Thr Ala Tyr Glu Thr Val Thr Ala Trp Pro Gly Ile Cys Ala Ser Asp
2645 2650 2655
Gly Asp Arg Thr Phe Gly Leu Val Val Lys Asp Val Gln Leu Thr Leu
2660 2665 2670
Phe Arg Asn Leu Asp Asp Lys Phe Tyr Leu Thr Pro Arg Thr Met Tyr
2675 2680 2685
Gln Pro Arg Val Ala Thr Ser Ser Asp Phe Val Gln Ile Glu Gly Cys
2690 2695 2700
Asp Val Leu Phe Val Asn Ala Thr Val Ser Asp Leu Pro Ser Ile Ile
2705 2710 2715 2720
Pro Asp Tyr Ile Asp Ile Asn Gln Thr Val Gln Asp Ile Leu Glu Asn
2725 2730 2735
Phe Arg Pro Asn Trp Thr Val Pro Glu Leu Thr Phe Asp Ile Phe Asn
2740 2745 2750
Ala Thr Tyr Leu Asn Leu Thr Gly Glu Ile Asp Asp Leu Glu Phe Arg
2755 2760 2765
Ser Glu Lys Leu His Asn Thr Thr Val Glu Leu Ala Ile Leu Ile Asp
2770 2775 2780
Asn Ile Asn Asn Thr Leu Val Asn Leu Glu Trp Leu Asn Arg Ile Glu
2785 2790 2795 2800
Thr Tyr Val Lys Trp Pro Trp Tyr Val Trp Leu Leu Ile Gly Leu Val
2805 2810 2815
Val Ile Phe Cys Ile Pro Leu Leu Leu Phe Cys Cys Cys Ser Thr Gly
2820 2825 2830
Cys Cys Gly Cys Ile Gly Cys Leu Gly Ser Cys Cys His Ser Ile Cys
2835 2840 2845
Ser Arg Arg Gln Phe Glu Asn Tyr Glu Pro Val Glu Lys Val His Val
2850 2855 2860
His His His His His His
2865 2870
<210> 3
<211> 60
<212> DNA
<213> 人工序列(Artificial Sequence)
<400> 3
atggtgtccg ctattgtgtt atacgtcctg ttagctgctg ccgcgcacag tgcctttgcg 60
<210> 4
<211> 4104
<212> DNA
<213> 人工序列(Artificial Sequence)
<400> 4
ttgcctcaag acgttacacg atgctctgca aacacaaact tccgacgatt cttctcaaaa 60
ttcaacgtgc aggcaccagc agttgtagtt ctaggaggat acctgccaat cggagagaat 120
caaggagtta actctacatg gtactgcgca ggacagcatc caacagcatc cggcgttcat 180
ggtatattcg tttctcatat ccgaggagga catggattcg aaatcggaat ctctcaggaa 240
ccattcgatc catctggata ccagctttac cttcataaag caacaaacgg aaacacaaac 300
gcaacagcac gacttcgaat ctgccagttc ccatctatca agaccttagg accaacagca 360
aacaacgatg ttacaacagg acgaaactgc ttattcaaca aggccatacc agcacatatg 420
tctgaacatt ctgttgttgg aatcacatgg gataacgatc gagttacggt attcagcgat 480
aagatatact acttctactt caagaatgac tggtctcggg tagctactaa atgctataac 540
tctggaggat gcgcaatgca gtacgtttac gaaccaacat actacatgct taatgtcacc 600
tccgccggcg aagatggaat ctcttaccag ccatgcacag caaactgcat cggatactct 660
gctaatgtct ttgcgaccga accaaacgga catatcccag aaggattcag cttcaacaac 720
tggttcttgc ttagtaatga ttccacgttg gtgcacggga aggtggtgtc gaatcagcca 780
ctactagtga attgtttatt ggcgatccca aagatatatg gacttggaca gttcttcagc 840
ttcaatcaaa ctatagacgg cgtgtgtaat ggtgctgccg tgcagcgagc accagaagca 900
cttcgattca acatcaacga tacatctgtt atccttgcag aaggatctat cgttcttcat 960
acagcacttg gaacaaactt cagcttcgtt tgctctaact cttctgatcc acatcttgca 1020
acattcgcaa tcccacttgg agcaatccag gttccatact actgcttcct taaagttgat 1080
acatacaact ctacagttta caaattcctg tcagtgttgc ctcctacggt gagagagatt 1140
gtcatcacaa agtatggcga tgtttacgtt aacggattcg gataccttca tcttggactt 1200
cttgatgcag ttacaatcaa cttcacagga catggaacag atgatgatgt ttctggattc 1260
tggacgattg caagcaccaa ctttgtcgat gcgctaatcg aagttcaggg cacggctatt 1320
caaaggatcc tttactgcga tgatccagtt tctcagctta aatgctcaca ggtcgctttc 1380
gatcttgatg atggcttcta ccctatcagc tctcgaaacc ttctttctca tgaacaaccc 1440
attagtttcg tggccctgcc gtcatttaat gaccattctt tcgtgaacat tacggtatca 1500
gcatctttcg gaggacattc tggagcaaac cttatcgcat ctgatacaac aatcaacgga 1560
ttcagtagtt tctgcgtgga tacacgacag tttactatca gcttattcta taatgtaaca 1620
aactcgtatg gctacgtttc taaatctcag gattctaact gcccattcac acttcagtct 1680
gttaacgatt acctttcttt cagtaaattc tgcgtgtcta cctcactctt ggccagtgct 1740
tgtaccatcg atctctttgg ttacccagaa ttcggatctg gagttaaatt cacatctctt 1800
tacttccagt tcacaaaggg tgagttgatt accggtacta gcaaaccact tgaaggtgtt 1860
acggacgtca gcttcatgac cttagacgtc tgtacaaagt atactattta tggattcaaa 1920
ggagaaggaa tcatcacatt aacaaacagc tcgttcttag caggagtata ttatacttca 1980
gacagtggac aactgttggc gttcaagaat gtaacgagtg gcgctgtata tagcgtaacg 2040
ccgtgcagct tctccgagca ggcagcatac gttgatgatg atatagtggg tgtcatttca 2100
tctctttctt cttctacatt caactctaca cgagaacttc caggattctt ctaccacagc 2160
aatgacggta gcaattgtac tgagccggtt cttgtttata gtaatatagg cgtatgcaag 2220
agcggttcta tcggatacgt tccatctcag tctggacagg ttaagatagc gcccaccgtt 2280
acaggaaaca tctctatacc gacaaacttt agcatgagta tccgaacaga ataccttcag 2340
ctttacaaca ctcctgtgtc cgtagactgc gcaacatacg tgtgcaacgg taacagtaga 2400
tgcaaacagc tgttaaccca atatactgcg gcatgcaaga ccattgaatc tgctctccaa 2460
ctctccgcgc ggctggagtc ggtcgaagtt aactctatgc ttacaatctc tgaagaagct 2520
ttacaattag cgaccataag tagctttaat ggagatggtt ataatttcac caacgttctt 2580
ggagtttctg tttacgatcc agcatctgga cgagttgttc agaaacgatc tttcattgag 2640
gacctgctct ttaataaggt cgttacgaat ggtctcggta ctgtagacga ggactataag 2700
agatgtagta acggacgatc tgttgcggac ttggtatgtg ctcaatatta ttccggtgtt 2760
atggtcttgc ccggtgtagt cgatgcagag aagttgcaca tgtattctgc atctcttatc 2820
ggaggaatgg tgttgggtgg gtttacctct gcagcagcac ttccattctc ttacgccgta 2880
caagctcgtt tgaattatct tgcgctacaa actgatgttc tccagcggaa ccagcaactg 2940
ctcgcggagt cgtttaatag tgccattggg tctatcacat ctgcattcga atccgtcaag 3000
gaggctatat ctcagacatc taaaggactt aacacagttg cacatgcact tactaaggtc 3060
caagaagttg ttaactctca gggagcagca cttacacagc tgacggtgca attacaacac 3120
aatttccagg cgataagcag tagtatagac gacatctact ctcgacttga tatcctctca 3180
gctgacgtgc aggtagaccg cctaataact ggacgactta gcgcactgaa tgctttcgta 3240
gcacagacgt taaccaagta tacagaagtt cgtgcttccc gtaaacttgc tcagcagaag 3300
gtcaacgaat gcgtaaagag tcagtcgcaa cgctatggat tctgcggtgg agacggcgaa 3360
catatcttct ctcttgttca ggcagcacca cagggactct tatttctgca cactgtccta 3420
gtaccgggag actttgtcga tgtaatcgct atagcaggac tttgcgttaa cgatgaaatc 3480
gcacttacac ttcgagaacc aggacttgtt ctgtttactc atgaacttca gaaccataca 3540
gcaacagaat acttcgtttc ttctcgacga atgttcgaac cacgaaagcc gaccgtcagt 3600
gactttgtgc aaattgagtc ctgtgttgtt acatacgtta accttacacg agatcagctt 3660
ccagatgtta taccggatta catcgatgta aacaagacct tagatgaaat tctcgcttcg 3720
ctcccgaacc gaacaggacc atctcttcct ctagacgtgt tcaacgcaac gtatttaaat 3780
ctcacgggtg agatcgcaga tcttgaacaa cgatctgaat ctcttcgaaa cacaacagaa 3840
gaacttcagt ctcttatcta caatataaat aatacattag tggatctgga atggctcaat 3900
cgggtcgaga catacatcaa gtggccgtgg tgggtgtggc ttatcatctt catcgttctt 3960
atcttcgttg tatccctgct agtattctgt tgtatatcta ccggatgctg cggttgctgc 4020
ggttgctgct gtgcgtgctt ctctggatgc tgccgaggac cacgacttca gccatacgaa 4080
gtctttgaga aagttcatgt ccaa 4104
<210> 5
<211> 18
<212> DNA
<213> 人工序列(Artificial Sequence)
<400> 5
catcaccacc accaccac 18
<210> 6
<211> 63
<212> DNA
<213> 人工序列(Artificial Sequence)
<400> 6
ggctcaggag aaggacgagg atctcttctt acatgcggag atgttgaaga gaatcccgga 60
cca 63
<210> 7
<211> 57
<212> DNA
<213> 人工序列(Artificial Sequence)
<400> 7
gtctccgcca tagtattgta cgtacttctc gccgccgctg cccactcagc ctttgcc 57
<210> 8
<211> 4290
<212> DNA
<213> 人工序列(Artificial Sequence)
<400> 8
gacaatttcc catgctctaa acttactaat aggacgatag gcaaccagtg gaaccttatc 60
gaaacattcc ttcttaacta ctcttctcga cttccaccaa actctgatgt ggtgttgggc 120
gactatttcc caacagttca gccatggttc aactgcatcc gaaacgacag caatgacttg 180
tatgtgaccc tggagaatct aaaggcgtta tactgggatt acgcaacaga gaatattaca 240
tggaaccatc gacagcgact taacgttgtt gttaacggat acccatactc tatcacagtt 300
acaacaacac gaaactttaa tagtgctgag ggtgcaatca tctgcatctg caaaggatct 360
ccaccaacaa caacaacaga atcttctctt acatgcaact ggggctctga gtgccgactt 420
aaccataaat tcccaatctg cccatctaac tctgaagcaa actgcggaaa catgctttac 480
ggacttcagt ggttcgcaga tgaagttgtt gcataccttc atggagcatc ttaccgaatc 540
tctttcgaga atcaatggtc tggaacagtt acattcggag atatgcgagc aacaacactt 600
gaagttgcag gaacgctcgt cgacctatgg tggttcaacc cagtttacga tgtttcttac 660
taccgagtta acaacaagaa tgggacaaca gtagtcagta attgtaccga tcagtgtgca 720
tcttacgttg ccaatgtgtt tacaacgcag ccaggaggat tcatcccatc tgatttttct 780
tttaataatt ggtttttgct tacaaatagc tccacactgg tgtcgggcaa attggtcaca 840
aagcagcctc tactcgtcaa ttgtctctgg cctgttccat ctttcgaaga agcagcatct 900
acattctgct tcgaaggagc aggattcgat cagtgcaacg gagcggtgtt aaacaacaca 960
gtggacgtaa tacgctttaa ccttaacttc acaacaaacg ttcagtctgg aaagggcgct 1020
acggtattct cactcaatac aacaggagga gtcacgctag agatttcatg ctacacagta 1080
tcggatagtt cattcttctc ctacggagag attccattcg gcgtaaccga cggccctcga 1140
tactgctacg ttcattacaa cggaacagca cttaaatacc ttggaacact tccaccatcc 1200
gtaaaggaga ttgctatctc taaatggggc cacttctata ttaacggcta taatttcttc 1260
tcaacctttc ccatcgattg catatcattt aatctgacga caggagattc tgatgtattc 1320
tggaccatag cgtatacgtc ttacacagaa gcattggtgc aagttgagaa taccgcaatc 1380
acaaaggtga cctactgcaa ctctcatgtt aacaacatca aatgctccca gataacagca 1440
aaccttaaca acgggttcta ccctgtaagc tcttctgaag tcgggctagt aaataagtct 1500
gttgtgttgc tacccagctt ctatactcat acaattgtga atattaccat tggccttgga 1560
atgaaacgat ctggatacgg acagcctata gcttcgactt taagtaacat cacacttcca 1620
atgcaggatc ataacacaga tgtttactgc atccgatctg atcagttctc tgtttacgtt 1680
cattctacat gcaaatctgc actttgggat aacatcttca aacgaaattg tacagatgtt 1740
ctagacgcga cagcagttat caagactggg acatgcccat tctctttcga taaacttaac 1800
aactacctta cattcaacaa attctgcctt tctctttctc cagttggagc aaactgcaaa 1860
ttcgatgttg cagcacgaac acgaacaaac gaacaggttg ttcgatctct ttacgttatc 1920
tacgaagaag gagataacat tgtcggtgtg ccgtcagata actcaggcgt tcatgacttg 1980
agtgtgctac acttagattc ttgcacagat tacaacatct acggacgaac aggagttgga 2040
atcatccgac agacgaatcg gactctactg tctggattat attatacgtc attaagcgga 2100
gatcttcttg gatttaagaa tgtgtcggac ggagttatct attcggtgac tccgtgcgac 2160
gtatctgcac aggcagcagt tatcgatgga acaatcgttg gagcaatcac atctatcaac 2220
tctgaacttc ttggacttac acattggaca acaacaccaa acttctacta ctactctatc 2280
tacaactaca caaacgatcg aacacgaggg acggctatag acagtaacga tgtcgattgc 2340
gaaccagtta tcacatattc gaatataggc gtgtgtaaga atggcgcttt cgtcttcata 2400
aacgttacac atagtgacgg cgacgtccag cccatttcta ctgggaatgt aacaattcct 2460
accaatttca ctatttcggt gcaagtcgaa tacatccagg tttacacaac gccggtatcc 2520
attgactgct ctcgatacgt atgcaacgga aaccctcggt gcaataagct gttgacacaa 2580
tatgtgtccg catgccaaac catagagcaa gcacttgcaa tgggagctcg actggagaat 2640
atggaggttg attctatgct gtttgtatct gagaatgcgc ttaaacttgc atctgttgaa 2700
gcattcaact cttctgaaac acttgatcca atctacaaag aatggccaaa catcggagga 2760
tcttggcttg aatctcttaa atacatcctt ccatctcata actctaaacg aaagtataga 2820
tctgcaatag aggacttact atttgacaaa gtggttacat ctgggttggg caccgtggac 2880
gaggactata agcgctgtac aggtgggtat gatatagccg atcttgtgtg cgcgcaatat 2940
tataatggta tcatggtcct cccgggaggg gctaatgcag ataagatgac gatgtacaca 3000
gcatctcttg catctggaat cacacttgga gcacttggag gaggagcagt tgcaatccca 3060
ttcgcagttg ctgtgcaagc gagactcaat tatgtggcgt tacaaaccga tgttctaaac 3120
aagaatcaac agatattagc atctgcattc aatcaggcaa tcggaaacat cacacagtct 3180
ttcggaaagg tgaatgatgc aatccatcag acatcccgag gacttgcaac agttgcaaag 3240
gctttagcga aagttcagga cgtagttaac atccagggac aggcactctc acacctgaca 3300
gttcaactgc agaacaactt ccaggcgatt agctcatcta tatcagacat ctacaaccga 3360
cttgatgaat tatccgctga cgctcaggtg gacagactaa tcacgggacg gctaaccgcg 3420
ctcaatgcgt ttgtaagtca gactctcacg cgccaagccg aggtgagggc gagtcggcaa 3480
ttggcaaagg acaaagtgaa cgaatgcgtt cgatctcaat cccaacgttt cgggttctgt 3540
ggaaatggga cacacttgtt ctctttagcc aacgcagcac caaacggaat gatcttcttc 3600
cacaccgtcc tactgcccac cgcgtacgaa acagttacag catggccagg aatctgcgca 3660
tcggacggcg acagaacctt tggtctagtc gtgaaggacg ttcagcttac attatttcgt 3720
aaccttgatg ataaattcta ccttacacca cgaacaatgt accagccacg cgtagcgact 3780
agttcagatt tcgttcagat agagggctgt gatgttctgt ttgtcaacgc cacggtttca 3840
gatttgccat ctatcatccc tgactatata gatattaacc agacagttca ggatatcctt 3900
gagaatttcc gtcccaactg gacagttcca gaacttacat tcgatatctt taatgccacc 3960
tatctgaatt taaccggtga aatagacgac cttgaattcc gatctgagaa gcttcacaat 4020
acgacagttg aacttgcaat ccttatcgat aatattaata ataccttagt gaatttagag 4080
tggctgaatc ggatagagac atacgttaag tggccctggt atgtctggct tcttattggg 4140
ttggtcgtaa tattctgtat accacttctt ctcttctgct gttgcagcac tggttgctgc 4200
gggtgcatcg gatgccttgg atcttgctgc cattctatct gctctcgacg acaatttgag 4260
aattatgaac cagttgagaa ggttcacgtg 4290
<210> 9
<211> 18
<212> DNA
<213> 人工序列(Artificial Sequence)
<400> 9
caccaccatc atcatcat 18

Claims (10)

1.一种猪流行性腹泻、猪传染性胃肠炎病毒病二联亚单位疫苗的制备方法,其特征在于,包括以下步骤:
1)将PEDV-T2A-TGEV-S序列克隆到杆状病毒转移载体中,得到重组质粒;
所述PEDV-T2A-TGEV-S序列的核苷酸序列如SEQ ID No.1所示;
2)将所述步骤1)得到的重组质粒转化感受态细胞、蓝白斑筛选,得到重组克隆;
3)将所述步骤2)得到的重组克隆转染昆虫细胞,得到重组病毒,将所述重组病毒感染昆虫细胞,感染24h后,将丝氨酸蛋白酶抑制剂、天冬氨酸蛋白酶抑制剂、氨基肽酶抑制剂、半胱氨酸蛋白酶抑制剂、丝氨酸/半胱氨酸蛋白酶抑制剂与培养基混合,得到含蛋白酶抑制剂培养物,将所述含蛋白酶抑制剂培养物继续培养48h,得到含有表达蛋白的培养物;
所述含蛋白酶抑制剂培养物中丝氨酸蛋白酶抑制剂的浓度为2μg/ml;
所述含蛋白酶抑制剂培养物中天冬氨酸蛋白酶抑制剂的浓度为1μM;
所述含蛋白酶抑制剂培养物中氨基肽酶抑制剂的浓度为10μM;
所述含蛋白酶抑制剂培养物中半胱氨酸蛋白酶抑制剂的浓度为10μM;
所述含蛋白酶抑制剂培养物中丝氨酸/半胱氨酸蛋白酶抑制剂的浓度为100μM;
4)将所述步骤3)得到含有表达蛋白的培养物离心,得到培养上清液,将所述培养上清液经30kDa超滤膜超滤、镍柱亲和层析,得到纯化的蛋白,将所述纯化的蛋白与佐剂混合,得到猪流行性腹泻、猪传染性胃肠炎病毒病二联亚单位疫苗。
2.根据权利要求1所述的制备方法,其特征在于,所述丝氨酸蛋白酶抑制剂包括Aprotinin;
所述天冬氨酸蛋白酶抑制剂包括PepstatinA;
所述氨基肽酶抑制剂包括Bestatin;
所述半胱氨酸蛋白酶抑制剂包括E-64;
所述丝氨酸半/胱氨酸蛋白酶抑制剂包括Leupeptin。
3.根据权利要求1所述的制备方法,其特征在于,所述步骤4)蛋白的氨基酸序列如SEQID No.2所示。
4.根据权利要求1所述的制备方法,其特征在于,所述步骤1)杆状病毒转移载体包括pFastBacl载体。
5.根据权利要求1所述的制备方法,其特征在于,所述步骤2)感受态细胞包括感受态细胞DH10Bac。
6.根据权利要求1所述的制备方法,其特征在于,所述昆虫细胞包括Sf9、Sf21、Tn5、Tn368和High Five细胞中的任一种。
7.根据权利要求1所述的制备方法,其特征在于,所述步骤3)将传3代以后的重组病毒感染昆虫细胞。
8.根据权利要求1所述的制备方法,其特征在于,所述步骤3)培养基以水为溶剂,每升包括45.9g Grace昆虫培养基、0.35g碳酸氢钠、3.3g水解乳蛋白和3.3g酵母提取物,所述培养基的pH值为6.2。
9.根据权利要求1所述的制备方法,其特征在于,所述步骤3)培养的总时间为96h。
10.根据权利要求1所述的制备方法,其特征在于,所述步骤4)蛋白与佐剂的质量比为1:1,所述佐剂包括ISA201VG。
CN202010492987.9A 2020-06-03 2020-06-03 一种猪流行性腹泻、猪传染性胃肠炎病毒病二联亚单位疫苗的制备方法 Active CN111607615B (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010492987.9A CN111607615B (zh) 2020-06-03 2020-06-03 一种猪流行性腹泻、猪传染性胃肠炎病毒病二联亚单位疫苗的制备方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010492987.9A CN111607615B (zh) 2020-06-03 2020-06-03 一种猪流行性腹泻、猪传染性胃肠炎病毒病二联亚单位疫苗的制备方法

Publications (2)

Publication Number Publication Date
CN111607615A CN111607615A (zh) 2020-09-01
CN111607615B true CN111607615B (zh) 2022-03-01

Family

ID=72198770

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010492987.9A Active CN111607615B (zh) 2020-06-03 2020-06-03 一种猪流行性腹泻、猪传染性胃肠炎病毒病二联亚单位疫苗的制备方法

Country Status (1)

Country Link
CN (1) CN111607615B (zh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116024244B (zh) * 2022-08-04 2023-09-22 长沙爱科博生物科技有限公司 一种融合蛋白基因及其应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110882384A (zh) * 2019-12-17 2020-03-17 天康生物股份有限公司 猪流行性腹泻-猪梭菌性肠炎二联亚单位的口服疫苗及制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1783228A1 (en) * 2005-11-08 2007-05-09 ETH Zürich Recombinant expression of multiprotein complexes using polygenes
CN104805106B (zh) * 2014-05-14 2018-07-03 北京市农林科学院 含tgev及pedv保护性抗原的融合基因及其编码蛋白和应用
CN104873966B (zh) * 2015-04-20 2019-12-20 浙江海隆生物科技有限公司 一种猪圆环病毒2型病毒样颗粒纯化及其疫苗制备方法
WO2017132332A1 (en) * 2016-01-28 2017-08-03 Svenska Vaccinfabriken Produktion Ab Chimeric hepatitis d virus antigen and hepatitis b virus pre s1 genes for use alone or in vaccines contaning hepatitis b virus genes
CN107158371A (zh) * 2017-05-16 2017-09-15 青岛农业大学 一种基因工程亚单位二联口服疫苗
CN107899008B (zh) * 2017-11-08 2019-05-10 陕西诺威利华生物科技有限公司 一种猪流行性腹泻、猪传染性胃肠炎、猪丁型冠状病毒病三联亚单位疫苗
CN110917343B (zh) * 2019-12-06 2023-09-26 江苏省农业科学院 一种新城疫与传染性法氏囊病二联亚单位疫苗
CN111217916B (zh) * 2020-01-15 2023-08-01 扬州大学 猪三种致腹泻病毒中和抗原表位融合蛋白及其构建方法和应用

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110882384A (zh) * 2019-12-17 2020-03-17 天康生物股份有限公司 猪流行性腹泻-猪梭菌性肠炎二联亚单位的口服疫苗及制备方法

Also Published As

Publication number Publication date
CN111607615A (zh) 2020-09-01

Similar Documents

Publication Publication Date Title
CN112876570B (zh) 非洲猪瘟病毒疫苗及其制备方法
CN110279855B (zh) 猪塞内卡病毒新型基因工程疫苗,其制备方法与应用
CN100582122C (zh) O型口蹄疫病毒多表位粘膜免疫疫苗及其应用
CN101270155B (zh) 通过耐酸性改造在昆虫中组装口蹄疫病毒空衣壳的方法
CN106834352B (zh) 基于杆状病毒表达系统制备包裹鲤疱疹病毒ii型抗原的多角体的方法
TWI554609B (zh) 抗豬生殖與呼吸綜合症病毒感染之重組融合抗原基因、重組融合抗原蛋白及含彼之次單位疫苗組成物
KR20190110605A (ko) 돼지 코로나바이러스 백신
CN103585625A (zh) 一种猪流行性腹泻重组杆状病毒基因工程亚单位疫苗及其制备方法与应用
CN113461788B (zh) 猫冠状病毒重组抗原、其基因工程亚单位疫苗及应用
CN110256539B (zh) O型口蹄疫病毒新型基因工程亚单位疫苗
CN107227311B (zh) 重组猪细小病毒样粒子及其制备方法和应用
CN111040024A (zh) 4型禽腺病毒基因工程疫苗及其制备方法与应用
CA2592366A1 (en) Recombinant foot and mouth disease vaccine
CN111607615B (zh) 一种猪流行性腹泻、猪传染性胃肠炎病毒病二联亚单位疫苗的制备方法
AU2020103776A4 (en) Koi herpesvirus (khv) orf-149-based carbon nanotube supported nucleic acid vaccine and application thereof
CN112679586A (zh) H5、h7亚型禽流感病毒基因工程亚单位疫苗及其制备方法与应用
CN110669142B (zh) 融合rgd的猪圆环病毒2型病毒样颗粒、突变型感染性克隆及其制备方法和应用
CN113862284B (zh) 一种编码重组禽流感病毒ha蛋白的基因、病毒样颗粒、疫苗及制备与应用
CN113896773B (zh) 重组fcv抗原及猫嵌杯病毒基因工程亚单位疫苗
CN113061167B (zh) 兔出血症病毒重组抗原及其应用
CN111518222B (zh) 牛轮状病毒融合蛋白和犊牛腹泻多联疫苗
CN114058524A (zh) 一种法氏囊亚病毒颗粒疫苗及其制备方法
CN110747215A (zh) 一种高效表达猪瘟e2蛋白的重组杆状病毒及其构建方法
CN112592410B (zh) 犬腺病毒基因工程亚单位疫苗、其制备方法及应用
CN112442130A (zh) 基于自组装铁蛋白纳米抗原颗粒及由其制备的狂犬疫苗和应用

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant